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Numerous natural and anthropogenic chemicals interact with endocrine systems of 
animals.  The most widely studied of  these endocrine active chemicals (EACs) are 
estrogen receptor agonists and antagonists.  Because of  the many important roles of 
estrogens in animals, xenoestrogens have the potential to impact environmental health.  It 
has been proposed that xenoestrogen contaminants are responsible for recent increases in 
estrogen dependent human diseases and sexual and developmental abnormalities in 
wildlife.  Aquatic species are particularly susceptible to persistent EACs that accumulate in 
sediments and biomagnify along trophic levels.  Rainbow trout, Oncorhynchus mykiss, 
commonly used in biomedical research and as a sentinel species, was chosen as a model 
for studying mechanisms ofxenoestrogen activity.  The aims of  this research were to 
assess the estrogenic activity of  individual persistent, organic contaminants and simple 
mixtures in vivo.  Emphasis was placed on determining the potential for xenoestrogens to 
alter sexual development or to induce sexually dimorphic biochemical responses.  Gonadal 
abnormalities in trout exposed as embryos to the xenoestrogen o,p'-DDE showed that 
xenobiotics can affect trout sexual development.  However, the absence of  endocrine 
Redacted for Privacydisruption by low doses of  o,p'-DDE, by the xenoestrogens chlordecone and octylphenol, 
or by the anti-androgen p,p'-DDE, suggested that lethality is likely to precede endocrine 
disruption in highly exposed, feral salmonid populations.  Sexually distinct responses in 
immature trout were documented with respect to vitellogenin induction (2 to 4 fold higher 
in females) and cytochrome P450 expression.  Sex differences occurred only when doses 
of  estrogens or xenoestrogens were below levels that cause maximal estrogenic responses. 
Evidence suggests that estrogen regulation may be fundamentally different in immature 
males and females, which may have implications for natural populations exposed to 
xenoestrogens.  Vitellogenin induction and P450 modulation were responsive to mixtures 
of  estrogens and xenoestrogens in a manner suggestive of  additive activation of  estrogen 
receptors.  Cytochrome P450 dependent induction of  lauric acid hydroxylation was 
observed for the first time in trout, in response to tamoxifen and mixtures oftamoxifen 
and  17~-estradiol.  The estrogenic activity oftamoxifen and 4-hydroxy-2',4',6'-
trichlorobiphenyl were greater in vivo than what was predicted by in vitro studies, which 
emphasized the need for mechanism based investigations of  xenoestrogens in whole 
orgamsms. © Copyright by David B. Carlson 
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Background 
Endocrine toxicology has received much attention in the latter half  of  this century. 
A series of  events in the early part of  this decade, including hypotheses linking human 
breast cancer (1-4) and decreasing sperm counts (5,6) to toxic chemicals, coupled with 
disturbing fish and wildlife data (7-12), have created renewed awareness to a historical 
problem.  Since the 1950s, scientists have known that certain xenobiotics interact with 
hormone systems in animals (13).  The majority of  both historical and modem research on 
endocrine modulating chemicals has focused on steroid hormones, particularly estrogens. 
Silent Spring (14), by Rachael Carson, struck a chord with the American public by 
implicating pesticides and organochlorine chemicals such as DDT, as the cause of 
abnormalities and declining populations in birds and wildlife.  Studies in the scientific 
literature had shown that DDT and other chemicals were estrogenic in animals (15-22), 
but those findings had not gained the attention of  the public as a whole.  While the cause 
of  population declines in predatory birds due to eggshell thinning was eventually linked to 
DDTs and metabolites (DDEs), the mechanism involved changes in enzyme function and 
sequestering Ca
2
+ for shell formation (23,24).  In subsequent years, research in endocrine 
toxicology became sufficiently broad that a common link between many studies was lost. 
Two conferences on "Estrogens in the Environment", in 1979 and 1985 (25,26), provided 
a forum for discussion of  estrogen modulating chemicals, but it wasn't until 1991 that 
scientists from a variety of  fields were brought together at the "Wingspread Conference" 
(27) that the breadth of  related endocrine toxicology research was realized.  Public interest 
was piqued as the popular press published stories on the issue that has been commonly called "endocrine disruption".  Stories with titles such as "Hormone Hell" (28) and "The 
Gender Benders" (29) undoubtedly caught the attention of  the United States Congress, 
which passed provisions contained in the Safe Drinking Water Act (1996) and the Food 
Quality and Protection Act (1996) that require the Environmental Protection Agency 
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(U.S. EPA) to identify screening tools for testing estrogenic activity of  new chemicals this 
year, and to start chemical screening in 1999.  Public television recently aired a program of 
Frontline (2 June, 1998) dedicated to the endocrine disruption issue and the consequences 
of  congressional testing mandates.  It is fair to say that "endocrine disruption" is an issue 
of  toxicological interest that has attracted the attention of  the American public. 
The descriptive term "endocrine disruption" has been coined to descn"be all 
chemical interactions with the hormone systems of  animals.  Strong evidence exists that 
populations of  animals, including trout in the United Kingdom (7,8) and alligators in 
Florida (9,10), have been affected by chemicals in heavily contaminated areas.  Humans 
have suffered ill effects from the pharmacological estrogen diethylstilbestrol (DES), 
ingested by pregnant women in the 1950s and 1960s to prevent spontaneous miscarriage, 
resulting in sexual abnormalities and unusual hormonally dependent cancers in people 
exposed in utero (30,31).  In such cases, normal function of  the endocrine system has been 
disrupted and the term "endocrine disruption" is an accurate description of  the 
consequences.  However, the ability of  chemicals to interact with components of 
endocrine systems does not prove that "disruption" ofnormal physiological activity has 
occurred.  Better terms for chemicals that interact with hormone systems are "endocrine 
active chemicals" (EACs) or "endocrine modulating chemicals" (EMCs), neither of  which 
have gained widespread use.  For lack of  an accurate, widely used term, the most general description of  "endocrine active chemicals", or EACs, will be used within this body of 
work. 
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Aquatic populations are particularly susceptible to EACs.  EACs are released into 
aquatic systems in bleached kraft mill efiluent (BKME) from paper mills and in treated 
sewage efiluent (32,33).  Other chemicals accumulate in sediments, which are slowly 
released into water and bioaccumulate and bioconcentrate in animals.  Evidence from field 
studies suggest that various populations ofaquatic vertebrates have been affected by 
human derived EACs.  Pr!!datory bird populations exposed to EACs, described by Rachel 
Carson, have rebounded but exposure to widespread, low level contamination persists and 
the topic has recently been reviewed (24).  Feminization offeral fish in the United 
Kingdom is thought to be caused by contaminants in sewage outfall, including 
alkylphenols and pharmacological estrogens (7,8,34).  Male alligators in heavily 
contaminated Lake Apopka, Florida, have small penises thought to be caused by the 
demasculinizing effects ofthe DDT metabolite p,p'-DDE (9,10).  Reviews from the 
Wingspread Conference discussed the role of  organochlorines in sexual abnormalities 
observed in Great Lakes salmon and marine mammals (11,12), as well as the unknown 
causes of  masculinization offish in the Southeastern United States (35).  Sufficient 
evidence suggests that populations in heavily contaminated areas have been affected by 
EACs, but less research exists to implicate residual environmental contamination in 
endocrine disruption. 
Recent interest in endocrine toxicology surged after reports implicating EACs in 
human health abnormalities.  Selected populations are exposed to high levels ofEACs in 
chemical manufacturing, pesticide application and farming, point-source pollution, and 5 
diets high in contaminated foods (36-40).  Breast cancer rates have increased in the past 
50 years and a preliminary epidemiological study reported a correlation between EACs 
and cancer incidence (2).  Results in several subsequent studies have been mixed, but the 
most comprehensive data have failed to establish a link between organochlorine EACs and 
breast cancer (3,4,37,41).  Worldwide declines in male spenn counts were described and 
attributed to EACs in a 1993 report (5).  Several studies showed that spenn counts have 
declined in certain geographical regions, but not globally (6,42,43).  A role for estrogens 
in the male reproductive system has been discovered (44), which may be a target ofEACs; 
however, no causes of  declining spenn counts or other male reproductive system 
anomalies have been proven (37,4S,46). 
There is evidence that humans are sensitive to exposure to exogenous estrogens. 
In utero exposure to diethylstilbestrol (DES) has been linked to rare vaginal cancers in 
women and sex organ alterations in men (30,31).  A major difference between DES and 
other EACs is that DES, a potent, pharmacological estrogen, was taken intentionally in 
high doses.  The general human population is exposed to very low levels of  persistent 
EACs, although certain lipophilic EACs accumulate in animal and human tissues. 
Developmental exposure to EACs in utero and through breast milk has been documented 
in infants (39,47), some of  whom are thought to have suffered permanent detrimental 
effects on learning and cognitive function (48,49).  Research continues to investigate the 
role ofEACs in human health, but at the present time, it is difficult to make any 
conclusions about adverse health effects of  environmental EACs (37,46,50). 
Interest in EACs is due, in part, to the large numbers of  chemicals and chemical 
classes that interact with endocrine systems.  Xenoestrogens have received the most 6 
attention and study.  No clear structure-activity relationships have been detennined for 
chemicals that interact with estrogen receptors, but hydroxyl groups and aromatic rings 
seem to be important (Figure 1.1) (51,52).  Early work with organochlorines such as 
DDTs and chlordecone established their estrogenic activity in vivo (13,15,16,18-20). 
Interaction with estrogen receptors in vitro has recently been used to classify 
xenoestrogens (51,53-57).  Chemical classes with estrogen modulating activity include 
natural products (e.g. phytoestrogens:  genistein; coumestrol; f3-sitosterol), industrial 
chemicals (PCBs, surfactants, phthalates), pesticides and pollutants (DDT, chlordecone, 
methoxychlor, dioxins, BKME, sewage efiluent) and pharmaceuticals (DES, contraceptive 
estrogens).  Exposure to these chemicals is likely to occur simultaneously, so it is 
advantageous to understand the activity of  simple and complex mixtures, in addition to 
individual chemical effects.  Many of  these chemicals are lipophilic and resistant to 
degradation by design, which contributes to their bioaccumulation and persistence. 
Persistence is an important issue, because humans are exposed to larger amounts 
of  dietary phytoestrogens than any other EACs (50).  Phytoestrogens undoubtedly 
evolved as defense mechanisms in plants to disrupt reproduction in pest species.  Phase I 
and Phase II enzymes quickly metabolize xenoestrogens from plants, preventing 
accumulation and prolonged exposure (50,58).  Chemicals such as organochlorines (OCs) 
and alkylphenol ethoxylates (APEs), on the contrary, are difficult to metabolize and persist 
in animal lipid stores.  Partly because oftheir role in declining bird populations and 
endocrine modulating potential, the production and use of  OCs has ceased in most 
industrialized nations.  However, OCs are still widely used in developing countries, which 
has resulted in global atmospheric transport and ubiquitous contamination in Arctic 7 
Figure 1.1- Structures of  estrogenic chemicals.  (1) 17J3-estradiol (natural); (2) tamoxifen 
(pharmacological); (3) diethylstilbestrol (DES, pharmacological); (4) 4-hydroxy-2',4',6'-
trichlorobiphenyl (industrial contaminant); (5) nonylphenol (alkylphenolic contaminant); 
(6) o,p'-DDT (pesticide contaminant); (7) 4-hydroxy-2',3',4',5'-tetrachlorobiphenyl 
(industrial contaminant); (8) genistein (natural phytoestrogen); (9) chlordecone (pesticide 
contaminant) \/ 
:z: 
o 
z(c 
o  :z: 
:z: 
0 
o  :z: 
~ 
C'1 
0 
¢ 
0'  :r  u-u 
"'6 
GO  x: 
u 
¢ 
0  x 
J: 
8 
0  0 
1.0 
(j\ 
~ 
~ 
If) 
CD 
~ 
0 
J: 
J: regions and flora and fauna, including marine vertebrates and humans (12,59,60).  APEs 
are heavily used in sewage treatment works, which also contain pharmacological 
estrogens, contnbuting to ongoing pollution (33,34,61). 
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In vitro vs. in vivo 
A majority of  recent research in endocrine toxicology has followed the general 
trend in biology towards in vitro and molecular studies.  Many chemicals have been 
classified as steroid hormone mimics or antagonists, based on their interaction with 
receptors in vitro.  While reductionist approaches in mechanism based studies have 
provided a more accurate description of  chemical activity than the historical bioassay 
approach, endocrine systems are exquisitely complex in animals (see 62,63).  Perhaps the 
best approach is to combine mechanism based in vitro analyses with in vivo studies. 
Common approaches for in vitro EAC characterization include:  receptor binding 
studies (51,53,56,57,64,65); stable and transient transfections of  hormonally responsive 
genes (or promoter regions), in combination with reporter genes such as luciferase (54-
56,65-70); and studies using immortal cell lines and cultures that are responsive to natural 
estrogens (55,56,65,66,69).  Some advantages of  in vitro systems include the ability to 
screen large numbers of  chemicals quickly, to estimate ligand affinity for hormone 
receptors, and to gauge the strength of  ligand-receptor-DNA interactions.  A major 
disadvantage of  the in vitro approach is the potential lack of  regulatory elements (both 
positive and negative) present in intact organisms, including cell and tissue specific 
transcription factors, coactivators and repressors.  Physiological factors are also involved 
in hormone homeostasis, which may be altered by xenobiotics.  The activity ofEACs will 
depend, in part, on absorption and metabolism during exposure, partioning between 
aqueous and lipid compartments, and the effective concentration of  chemical at target 11 
sites.  Indeed, endocrine responses in whole organisms cannot necessarily be considered to 
consist ofthe sum of  their parts. 
Various examples in the literature illustrate in vivo responses that were different 
from in vitro predictions.  Welshons and colleagues observed that the estrogenicity of 
octylphenol was greater in mice than predicted, presumably due to interactions with serum 
binding proteins (71), and that prostates were enlarged in mice exposed in utero to low, 
but not high, doses of  estrogen and DES (72).  Studies with rainbow trout also showed up 
to 10 fold higher in vivo estrogenicity of  octylphenol than predicted, possibly due to 
bioaccumulation (34, 73).  Metabolism is necessary for many drugs and xenobiotics to be 
bioactivated, which has been shown to be important for the in vivo estrogenicity of  the 
pesticide methoxychlor (74).  Tamoxifen, designed to be an inlnbitor of  estrogen 
dependent breast tumors, was found to be an estrogen agonist in other tissues in vivo, 
indicating the importance of  tissue specific transcription factors in estrogen receptor 
activation (75).  An analysis of  the existing research with EACs led participants in a U.S. 
EPA sponsored workshop to conclude that in vivo characterization ofEACs should be a 
high priority (76). 
In addition to receptor interactions, a simplified look at steroid hormone regulation 
reveals multiple sites ofxenobiotic action, encompassing all endpoints influenced by 
endogenous steroids.  Synthesis of  steroids in endocrine glands and tissues is under the 
direct control of  gonadotropin hormones, which are regulated by the hypothalomo-
pituitary axis (62).  Steroids are involved in feedback loops that signal gonadotropin 
release, thereby influencing their own metabolism.  Proteins and lipoproteins in the blood 
bind to steroids, facilitating transport throughout the circulatory system and regulate 12 
movement across cell membranes (71).  Cytochrome P450 enzymes are likely sites of 
modulation by EACs because they are directly involved in steroid metabolism (77), they 
are involved in Phase I metabolism and bioactivation ofxenobiotics (78,79), and they are 
susceptible to induction, downregulation, and inhIbition by xenobiotics (79-82). 
Interference with receptor-DNA complexes is possible, not only through direct 
interactions with receptors, but by modifying binding to response elements and 
transactivation domains of  other proteins (83,84) or through cross-talk with other 
signaling pathways (85).  Regulation of  cell growth, including interactions with growth 
factors and proliferative activity in tumor cells (86), may be a target ofEACs. 
Alternatively, EACs could modulate endogenous estrogen function in positive ways by 
enhancing bone growth or activity at other non-target tissues (86,87). 
Physiological contnbutions and susceptibility of  animals to subtle endocrine 
modulating effects have not been widely explored.  Steroid hormones are involved in 
sexual determination and differentiation in most animals.  Lipophilic chemicals are often 
designed to cross the blood-brain barrier (e.g. the neurotoxic pesticides DDT and 
chlordecone) and they easily cross through the placenta to expose developing embryos. 
Evidence from animal models and humans have demonstrated that alterations in sex 
steroid levels during development can have profound effects including feminization, 
masculinization, and sex changes (31,88-92).  Many chemicals are also more toxic to early 
life stages of  animals, including endocrine systems (93,94).  Sex steroid expression and 
activity are different in males and females, therefore, chemicals that interact with steroids 
may have sex specific consequences.  Depending on the stage of  sexual development, toxicity may occur with respect to growth and development immediately, or effects may 
be delayed until sexual maturity is reached. 
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Hormone metabolizing enzymes and estrogen responsive genes are common 
targets of  xenobiotics.  Early studies with DDT showed that enzyme systems involved in 
hormone regulation could be altered, which contributed to endocrine toxicity (95,96). 
Recent evidence has built upon earlier work, showing that treatment with exogenous 
estrogens or xenoestrogens alters cytochrome P450 expression and activity (97-100) and 
estrogen-dependent proteins such as vitellogenin and 1actoferrin have proven useful as 
biomarkers of  estrogen exposure (101-103). 
A recurring concern in environmental research is the activity of  complex chemical 
mixtures in vivo.  Environmental health agencies such as the U.S. EPA regulate chemicals, 
and implement toxicity testing and health guidelines, based on the assumption that activity 
of  mixtures is additive.  The most common example of  this is the use of  toxic equivalency 
factors (TEFs) to assess the risk of  exposure to aryl hydrocarbon receptor (AbR) agonists 
based on the sum of  chemical affinity for AhR, compared to dioxin (104,105). 
Mechanistic laboratory studies usually focus on single chemicals or simple mixtures, but 
evidence exists in vitro and in vivo that suggests that synergistic interactions of  estrogenic 
chemicals are possible (85,106).  Functional synergy could occur between transcription 
factors (106) or through mechanisms that have not been documented, such as cross-talk 
between signaling pathways, conformational changes in gene promoter regions, or through 
multiple binding sites on receptors.  Interactions between different receptor subtypes (107) 
or with retinoic acid receptors (108) could lead to complex transcriptional regulation of 14 
estrogen receptors.  Investigations of  the toxicity of  mixtures will continue because of  the 
continuous exposure of  humans and wildlife to low levels of  complex chemical mixtures. 15 
Rainbow trout model 
Research in aquatic toxicology varies greatly, from environmental and regulatory, 
to biomedical and basic research.  Rainbow trout, Oncorhynchus mykiss, are desirable 
animal models for a variety of  reasons.  Trout are predatory fish, with a fairly high fat 
content, which makes them susceptible to bioaccumulation and bioconcentration of 
lipophilic contaminants (109).  Wild trout populations have been used as indicator species 
of  contamination (94,109,110) and fisheries biologists have studied salmonids because of 
their economic importance and use in aquaculture.  Rainbow trout have been widely used 
in biomedical research, particularly as a model for carcinogenesis (111) and in the 
characterization ofxenobiotic metabolizing enzymes (82).  Extensive knowledge of  trout 
biology, including steroid hormone systems, make them excellent models for endocrine 
toxicity research. 
Early life stages, particularly embryos and sac-fry, are more sensitive to 
xenobiotics than older fish (93,112) and endocrine development can be permanently 
altered by early exposures.  Sex determination in trout is thought to be governed by sex 
chromosomes (113), but sexual development can be manipulated by exogenous hormone 
treatments (90,114).  Sexual differentiation occurs between hatching and yolk-sac 
absorption (114,115), throughout which time EACs could cause irreversible changes in 
sexual development.  Examples of  xenobiotic induced changes in sexual differentiation 
exist, including:  sex inversion in all female gynogenetic lizards (116) and in turtles (117), 
caused by aromatase (CYP 19) inhibition; sex reversal in reptiles with temperature-
dependent sex determination by OH-PCBs (85); and abnormalities in trout gonads due to 
~---- --------------------_______________  --l 16 
developmental PCB exposure (118).  In utero expos~e  in humans and laboratory animals 
to steroid hormones or analogs can alter fetal sexual development in the absence of 
maternal toxicity, and problems may only be evident after sexual maturity (31). 
The modulation of  estrogen receptors, steroid metabolizing enzymes, blood 
transport proteins, hypothalamo-pituitary feedback loops, and estrogen-dependent gene 
products have been studied in trout with respect to natural hormone homeostasis.  All of 
those endpoints are targets of  xenoestrogens, either directly, or indirectly by altering 
endogenous hormone function.  A single trout estrogen receptor has been sequenced and 
cloned (119-121), though multiple mRNAs exist (120,122).  Two estrogen receptors have 
been characterized in mammals (107), which suggests that other trout ERs may exist 
(123).  ER is auto  induced in trout, resulting in upregulation of  receptor number by 
estrogens (64,124,125), ultimately saturating the response (125).  Mature female brown 
trout were shown to have higher ER expression than mature males (126), but rainbow 
trout express ER and ER responsive genes early in development at levels comparable to 
adult males (122).  Sex differences in juvenile fish have not been explored.  Species 
differences appear to exist in teleost ER sensitivity to xenoestrogens (53.127), but little 
work has been done to characterize fish responses to pharmacological antiestrogens or 
partial agonists.  Studies showed P450 sex differences in mature fish (128), which were 
supported by later evidence that estrogen exposure caused female fish to exhibit lower 
P450 levels (99. J  00).  Xenobiotic induced changes in steroid transport proteins or 
gonadotropins have not been studied extensively.  EACs have been shown to modify 
thyroid hormone status in animals, but specific work in fish is lacking (129-13  J). 
Induction of  the egg yolk protein precursor vitellogenin (Vg), which is dependent on 17 
estrogen receptor binding (132), has been used as a biomarker of  xenoestrogen exposure 
in trout (34,64,102).  The promotion of  liver cancer in trout by estrogens has also been 
documented (133), which is an additional potential endpoint of  estrogenic xenobiotics. 18 
Present studies 
This thesis research was designed to investigate effects of  xenoestrogens in 
rainbow trout, particularly whether endocrine function could be transiently or pennanently 
altered by in vivo exposure.  Because in vitro systems are necessarily more simplistic than 
intact organisms, mechanistic models do not always accurately predict results in animals. 
Specific questions of  interest were:  (1) can xenoestrogens alter normal sexual 
development?; (2) are early life stages exquisitely sensitive to EACs?; (3) are chemicals 
that are classified as xenoestrogens based on in vitro data also estrogenic in vivo?; (4) are 
estrogenic responses of  simple chemical mixtures equivalent to the sum of  individual 
chemicals?; and, (5) do sexually immature males and females respond similarly to 
xenoestrogens? 
Exogenously administered steroid hormones can alter sexual differentiation in 
salmonid fishes (90,114,134), which suggests that EACs may alter trout sexual 
development.  Chapter 2 contains information about rainbow trout that were exposed as 
embryos to persistent, lipophilic chemicals known to interact with steroid hormone 
receptors.  Treatments were designed to model maternal transfer of  chemicals to eggs, 
which results in continuous exposure to EACs throughout sexual deVelopment.  Multiple 
physiological and biochemical endpoints were studied, including gonadal morphology, 
histology, and in vitro steroid production.  Fish were also reared to maturity to examine 
the effect of  in ovo exposure on sexual maturation and reproductive potential. 
The estrogenicity of  PCBs and OR-PCB metabolites is discussed in Chapter 3. 
PCBs have been classified as estrogen agonists and antagonists based on their ability to 19 
bind directly to estrogen receptors and because of  interactions associated with Ah receptor 
binding.  Evidence from other species, including turtles and mice, demonstrated the 
estrogenicity of  various OH-PCBs in vivo (51,66).  An enzyme-linked immunosorbent 
assay (ELISA) for vitellogenin, modified from an existing method (64), was used to gauge 
estrogenicity.  Responses of  fish to single chemicals and mixtures of  natural estrogens and 
OH-PCBs were compared.  Immature fish at different stages of  sexual maturation were 
also compared in order to investigate sex and life stage sensitivity to chemical mixtures. 
Estrogens and steroid hormones have complex physiological functions.  While 
changes in gene transcription by estrogens are mediated through receptor-DNA 
interactions, regulation of  steroid metabolizing enzymes may be receptor dependent or 
independent.  Expression and activity of  cytochrome P450 enzymes involved in steroid 
and xenobiotic metabolism can be modulated by natural estrogens (99,100).  Studies 
descnbed in Chapter 4 investigated the mechanism ofP450 downregulation by  17~­
estradiol.  Tamoxifen, a partial estrogen receptor agonist and pharmaceutical agent in 
humans, was used as a model xenoestrogen in combination with 17~-estradiol to 
investigate the role of  estrogen receptors in P450 regulation.  Little is known about the 
activity oftamoxifen in trout and studies were designed to determine the potential of  a 
tissue-specific estrogen to induce vitellogenin or alter P450s.  Most EACs are weakly 
estrogenic, like tamoxifen, and may alter normal endocrine function by disrupting the 
physiological role of  natural estrogens. 
Prior to sexual maturation, rainbow trout and other salmonids are difficult to sex 
without using invasive techniques.  A prevailing assumption is that sexes are 
physiologically similar until maturation, when circulating sex steroid levels rise as gonads 20 
become fully functional.  Consequently, when trout are used as biomedical models, results 
from juveniles are often pooled and analyzed together.  Patmo and Schreck, however, 
showed evidence of  sexually dimorphic steroid production in immature salmon (135). 
Exposure to xenoestrogens and other EACs may have different consequences in fish of 
different sexes, because estrogens and androgens have different physiological roles.  In 
chapter 5, the sex-specific vitello genic responses of  immature fish to estrogens are 
compared. 
illtimately, scientists must assess the risk ofEACs to the general health of  animal 
and human populations.  The final chapter of  this thesis provides a brief  discussion of  the 
significance of  results presented here, as well as recommendations for future research. 
Observations in rainbow trout may be useful in uncovering mechanisms ofxenoestrogen 
induced endocrine toxicity and will provide a basis for species comparisons and insight 
into potential human health effects. 21 
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Chapter 2 
Salmonid Sexual Development Is Not Consistently Altered By Embryonic Exposure 
To Xenoestrogens 
David B. Carlson
l 
,  Lawrence R. Curtis2, and David E. Williams
l 
IDepartment of  Environmental and Molecular Toxicology and Marine Freshwater 
Biomedical Sciences Center, Oregon State University, Corvallis, OR; 2Department of 
Environmental Health, East Tennessee State University, Johnson City, TN Abstract 
Sexual development in fish is sensitive to exogenous hormone manipulation and 
salmonids have been used extensively as environmental sentinels and models for 
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biomedical research.  Maternal transfer of  contaminants was simulated by microinjection 
of  rainbow trout (Oncorhynchus mykiss) and chinook salmon (Oncorhynchus 
tshawytscha) embryos.  Fish were reared for six months, sexed, and gonads removed for 
histology and measurement of  in vitro steroid production.  Analysis of  fat samples showed 
that dichlorodiphenylethylene (DDE) levels, o,p'-DDE and p,p'-DDE isomers, were 
elevated six months after treatment.  A preliminary study showed an increased ratio of 
males:females after treatment with 80 mg/kg and 160 mg/kg of  the xenoestrogen o,p'-
DDE.  One fish treated with 160 mg/kg o,p'-DDE had gonads with cells typical of  both 
males and females.  A follow-up study, using more fish and excluding the highly toxic 160 
mg/kg o,p'-DDE dose, showed no effect on sex ratio or gonadal histology.  Embryonic 
exposure of  monosex male trout, mono  sex female trout, and mixed sex salmon to o,p'-
DDE, p,p'-DDE, mixtures ofDDE isomers, and octylphenol failed to alter sexual 
development.  No treatment dependent changes in in vitro gonadal steroid production 
were seen in any experiments.  Trout exposed in ovo, that were reared to maturity, 
spawned successfully.  These results suggest that lethality due to the xenoestrogens o,p'-
DDE, chlordecone, and octylphenol, and the anti-androgen p,p'-DDE, are likely to 
precede subtle changes in sexual development.  However, trout appeared to be sensitive to 
endocrine disruption, so we cannot dismiss the threat of  heavily contaminated sites or 
complex mixtures to normal sexual development of  salmonids or other aquatic organisms. 35 
Introduction 
Many anthropogenic and naturally occurring chemicals are known to interact with 
endocrine systems of  animals.  Organochlorine (OC) pollutants and alkylphenolic 
detergents are two classes of  persistent endocrine active chemicals (EACs).  OCs include 
industrial chemicals and contaminants such as polychlorinated biphenyls (PCBs) and 
polychlorinated dibenzo-p-dioxins (PCDDs), and insecticides such as DDT (and 
metabolites) and chlordecone (Kepone).  The production and use of  many OCs has ceased 
in most industrialized nations, however, their use continues in developing countries. 
Global atmospheric transport results in ubiquitous contamination, including Arctic regions, 
marine mammals, and humans (1-3).  Unlike OCs, production and use of  alkylphenol 
ethoxylate surfactants, particularly in sewage treatment works, is common and ongoing. 
The persistence and estrogenicity of  alkylphenols has been well documented and recently 
reviewed (4). 
Laboratory and field data have implicated OCs in impaired reproductive success 
and abnormal sexual development in fish and wildlife species.  DDT and metabolites have 
caused egg shell thinning and endocrine and reproductive toxicity in wild birds, altering 
population structure (5).  Sexual abnormalities reported in Florida alligators are thought to 
be caused by the demasculininizing effects of  DDT metabolites, includingp,p'-DDE (6,7). 
Reviews have discussed the role ofOC exposure in reproductive and sexual abnormalities 
in Great Lakes salmon (8) and marine mammals (2).  Feminization of  trout in United 
Kingdom rivers has been observed and is likely due to contaminants in sewage outfalls, 
including a1kylphenols and pharmacological estrogens (9,10).  Laboratory studies with 
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organochlorines and alkylphenols, including o,p'-DDE, chlordecone, and octylpheno~ have 
documented the estrogenicity of  these chemicals (4,11-13). 
Because honnones are involved in the etiology of  various human cancers, EACs 
have been predicted to increase cancer risks.  Selected human populations are exposed to 
high levels of  OCs from chemical manufacturing, heavy pesticide use, point-source 
pollution, and diets high in contaminated fish.  Correlations have been suggested between 
xenoestrogens and breast cancer (14) and declining spenn counts (15), however, causal 
links with adverse human health effects have not been established (reviewed in 16,17).  In 
utero exposure to DES, a potent non-steroidal pharmacological estrogen,  has been linked 
to rare vaginal cancers in women and sex organ alterations in men (18,19). 
Developmental exposure ofEACs to humans in utero and from breast milk has been 
documented (20) and implicated in permanent cognitive dysfunction (21). 
Rainbow trout, Oncorhynchus mykiss, have been studied extensively in fisheries, 
environmental, biomedic~  and endocrine research.  Lipophilic OCs and alkylphenols are 
resistant to metabolism, resulting in bioaccumulation in fish and subsequent human 
exposure from fish consumption.  Female fish transfer persistent chemicals to eggs, 
effectively clearing contaminant burdens but exposing developing embryos to EACs 
(22,23).  These chemicals may alter sexual development of  embryos, which has been 
documented in laboratory studies with other chemicals in fish and reptiles (24-26).  There 
is a great deal of  sexual plasticity in teleost fish, but sex steroid honnones appear to 
control sexual characteristics in all species (27,28).  Sexual differentiation likely occurs 
between hatch and yolk-sac absorption in rainbow trout (24,29,30).  Complete and partial 
feminization of  trout have been achieved by various estrogen treatments to eggs and fry L 
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(30,31) and androgens can be used to create functional all male populations of  salmonids 
(24,32).  Hormone receptor expression, endocrine feedback loops, and steroid 
metabolizing enzymes can be altered by chemical exposure (11,33-35).  Although 
physiological consequences may differ, biochemical and molecular functions of  steroid 
receptors in fish seem to be homologous to humans (36-38). 
In this study, we examined the effects of  the xenoestrogens o,p'-DDE, chlordecone 
and octylphenol, and the anti-androgen p,p'-DDE, on various endpoints of  sexual 
development in rainbow trout.  Differences in species sensitivity to the xenoestrogen o,p'-
DDE were investigated by comparing sexual development of  chinook salmon, 
Oncorhynchus tshawytscha, to rainbow trout.  Eggs containing eyed embryos were 
micro  injected with chemicals to ensure accurate dosing.  Developing fish were 
continuously exposed to contaminants throughout sexual development, modeling exposure 
to maternally transferred chemicals.  Sex ratios and gonadal morphology and histology 
were examined after six months.  Immature gonads were removed and incubated in vitro 
to determine steroid synthesizing potential of  exposed fish.  Fish were reared to sexual 
maturity and fertility and egg viability assessed.  Experiments were conducted with mixed 
sex populations, as well as single sex populations of  males and females. 38 
Materials and Methods 
Chemicals 
Two persistent metabolites ofl,l-dichlorodiphenyltrichloroethane (DDT), o,p'-
DDE (100% pure; 1, I-dichloro-2-(p-chlorophenyl)-2-(  o-chlorophenyl)ethylene) and p,p'-
DDE (100% pure; 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene) were obtained from 
AccuStandard (New Haven, CT).  4-tert-Octylphenol (OP; 97% pure) was purchased 
from Aldrich Chemical Co. (Milwaukee, WI).  Chlordecone (CD; 99.5% pure) was 
purchased from ChemService (West Chester, PA).  Ring-labeled C
4C]p,p'-DDE (> 95% 
pure; 12.7 J.lCi J.lmor1), [14C]CD (96% pure; 6.1  J.lCi J.lmor\ and salmon pituitary powder 
were from Sigma Chemical Co. (St. Louis, MO).  A mixture of  p,p'-DDE and o,p'-DDE 
(5.4:1) was prepared based on the ratio oftechnical grade DDT isomers and residual 
environmental levels (39,40).  All chemicals were dissolved in menhaden oil for 
microinjection of  embryos.  Sterile RPMI-1640 culture medium (without glutamine) and 
gentamicin sulfate (50 mg/ml) were purchased from Whitakker Bioproducts (Baltimore, 
MD). 
Embryo microinjections 
Mt. Shasta strain rainbow trout (Oncorhynchus mykiss) eggs were obtained from 
the MarinelFreshwater Biomedical Sciences Center aquaculture facility at Oregon State 
University.  Chinook salmon (Oncorhynchus tshawytscha) were obtained from the Fish 
Genetics and Performance Laboratory at Smith Farm, Oregon State University.  Fish were 
maintained and euthanized with the approval of  the Institutional Animal Care and Use 39 
Committee (IACUC) at Oregon State University.  Trout were maintained in tanks with 
continuously running well water, 12-14°C, on a 12 h light:dark photoperiod, except for 
EXP 1 and the maturation stage of  EXP 2, which were subjected to the natural 
photoperiod.  Eyed embryos (21  days post fertilization (DPF)), averaging ItO mg/egg, 
were micro  injected with 1 J.11 menhaden oil containing chemical (or vehicle only) directly 
into the yolk, using a Hamilton Micro  Lab 900 automated syringe pump fitted with a 31 g 
needle.  Microinjections have been used successfully to administer accurate carcinogen 
doses (41).  Preliminary range finding experiments showed that the DDE and chlordecone 
doses employed approximated LOAEL of  six month old fish injected ip, and OP doses 
were below levels lethal to embryos (unpublished data).  A total of  five microinjection 
experiments were performed as follows:  Experiment 1 (EXP 1)- mixed sex rainbow trout 
population, tOO eggs per treatment, in duplicate, at 40,80, or 160 mg/kg o,p'-DDE or 7.5, 
15, or 30 mg/kg chlordecone; Experiment 2 (EXP 2)- mixed sex rainbow trout population, 
150 eggs per treatment, in duplicate, at to, 40, or 80 mg/kg o,p'-DDE, to, 40, or 80 
mglkgp,p'-DDE, or to, 40, or 80 mglkg DDE mix; Experiment 3 (EXP 3)- monosex male 
trout, 100 eggs per treatment at 1, 40, or 80 mg/kg o,p'-DDE or 65 eggs per treatment at 
0.01,0.1, or 1 mg/kg OP; Experiment 4 (EXP 4)- mono sex female trout, 50 eggs per 
treatment, in duplicate, at 1, 10,40, or 80 mg/kg o,p'-DDE or 0.01,0.1, or 1 mg/kg OP; 
Experiment 5 (EXP 5)- chinook salmon, 85 - 100 eggs per treatment, in duplicate, 3 J.11 
injections at 1,  13.33,40, or 80 mglkg o,p'-DDE (except 40 mglkg and 13.33 mglkg (l J.11 
injection) were without replicate treatments).  Mortality was monitored over time and fish 
were reared for approximately 6 months, until gonads were large enough to easily sex and 
remove.  Mortality differences were analyzed by ANOVA after hatch and time of  first 40 
feeding after yolk absorption, two critical windows of  fish development.  Sex ratios were 
compared by Chi-square analysis. 
Gonad incubations and histology 
After approximately six months fish were anesthetized in a 50 mg/L solution of 
tricainemethanesulfonate (MS222).  Fish weights were recorded and sex was determined 
grossly by examination of  gonad morphology.  Gonads were removed and placed in 24 
well culture plates containing ice cold medium (RPMI-1640).  Fish were then killed by 
severing the spinal chord.  In vitro gonadal steroid production was measured using a 
modification of  the method of  Fitzpatrick et al. (30).  Gonads were washed twice in 1 m1 
RPMI-I640 containing 0.1% gentamicin for 1 h.  Steroid hormone production was 
induced by addition of 12.5 J-lg salmon pituitary powder into 1.25 m1 medium.  Gonads 
were incubated for 24 h at 4°C in sealed chambers saturated with a 95% O2:5% CO2 gas 
mixture.  Media was removed and stored at -80°C until measurement of  sex steroids by 
radioimmunoassay (30).  Preliminary experiments were performed to optimize sex steroid 
production and it was found that addition of 10 J-lg salmon pituitary extract per ml medium 
stimulated maximal steroid production by gonads and steroid levels increased linearly up 
to 24 h.  No sex steroids were detected in media alone or when gonads were incubated in 
the absence of  pituitary powder.  Histology of  gonads confirmed that tissues were viable 
after 24 h incubations.  Steroid production was compared between treatments by ANOV  A 
and the nonparametric Kruskal-Wallis Test (StatView v4.5, Abacus Concepts, Berkeley, 
CA). 41 
At least ten pairs of  gonads from each treatment were fixed in 10% buffered 
formalin for histological examination.  After fixation, tissues were embedded in paraffin 
and sectioned into 5 J.1m slices.  Sections (3-6 per gonad pair)were stained in haematoxylin 
and eosin and examined under light microscopy for sex specific gonad structures and germ 
cells. 
Residue analysis and  t'h 
Persistence ofDDE isomers and chlordecone were estimated in fish using 
radiochemicals.  Embryos (21 DPF) were injected with 10 or 80 mg/kg C
4
C]p,p'-DDE or 
7.5 or 15 mg/kg C 4C]chlordecone.  Eggs were maintained in an aerated, static water bath 
for 20 d, with subsamples removed and snap frozen in liquid N2 at time 0, 1 d, 7 d, and 20 
d.  Embryos or fry (hatch occurred at 25 DPF) were solubilized in 1 ml soluene and 
shaken overnight in a 37°C water bath.  Solutions were decolorized with 30% H20 2, 
cooled and radioactivity measured by liquid scintillation counting (Beckman LS6500), 
employing automatic quench and chemiluminescence correction.  Estimations of  residue t'h 
were determined by least squares regression (Microsoft Excel, v7.0). 
DDE residues were also measured in trout from EXP 2.  Fat samples taken 283d 
after egg injections were extracted with hexane and residues separated by column 
chromatography on deactivated alumina.  DDE isomers were measured on a gas 
chromatograph equipped with electron capture detector (Varian 3740) in the 
Environmental Chemistry and Toxicology Laboratory at Oregon State University. 
Detection limits for o,p'- and p,p'-DDE isomers were 0.02 and 0.01  J.1g/g fat, respectively. 42 
Sexual maturation 
A subset of  mixed sex trout from EXP 2 were reared for 2.5 years, in order to 
monitor sexual maturation.  Fish were maintained under a natural photoperiod for the :final 
six months prior to the winter spawning season.  Fish were then anesthetized in MS222 
and eggs removed from ripe females.  Total egg weight was compared to total fish weight 
to determine the gonadal somatic index (GSI) for individual females.  Total egg weight 
was compared to individual egg weight (average weight of30-50 eggs) which was used to 
estimate fecundity, or total eggs released.  Eggs from each female were fertilized with a 
mixture of  sperm from at least three stock (control) males.  Sperm from experimental 
males was used to fertilize eggs from two separate control females.  From each cross, 100 
eggs were removed immediately after fertilization and reared in incubation cups (PVC pipe 
with fine mesh bottoms) with continuously running water.  Fertilization success was 
determined after 24 h, timing of  hatch and hatch success were recorded, and egg 
mortalities were recorded until one week post-hatch.  Gonads offish that did not spawn 
were examined grossly to determine if  fish were maturing normally. 43 
Results 
Early life stages of  salmonids were more sensitive to o,p'-DDE and chlordecone 
than older fish.  Mortality (96 h) of  two month old fish injected i.p. with o,p'-DDE (160 
mg/kg highest dose) was 5% and with chlordecone (7.5 - 30 mg/kg doses) ranged from 10 
_ 35% (data not shown).  Mortality of  mixed sex trout injected as embryos, with 
equivalent doses of  o,p'-DDE was as high as 49% above oil injected controls (Table 2.1). 
Chlordecone (EXP 1) mortality ranged from 20 -45 % above oil injected controls (p < 
0.05), which increased in a dose-dependent manner.  Mortality in o,p'-DDE treated salmon 
(EXP 5) was no different than oil injected controls (Table 2.1).  In mono  sex trout 
populations, mortality in treatment groups did not differ from oil injected controls, 
however, injection itself increased mortality in males (Table 2.1).  Octylphenol exposure 
did not affect survival in a dose-dependent manner in monosex male or female trout (Table 
2.1).  While mortality was lower in monosex female treatments compared to monosex 
males (Table 2.1), these data are confounded by the fact that fish were genetically 
manipulated during fertilization.  Approximately 50% of  monosex males and 80 - 90% of 
monosex females died prior to chemical treatment, resulting in varying degrees of 
selection for hearty fish. 
Xenoestrogen treatment in EXP 1 resulted in increased ratios of  male: female at all 
doses.  Results were consistent between duplicate treatments and final analyses were 
performed on pooled data from tanks containing replicates.  There were significantly more 
males than females in 80 and 160 mg/kg o,p'-DDE treated fish (Figure 2.1).  Trends from 
chlordecone treatments suggested increased male:female (1.9, 1.25, and 2.25 at 7.5, 15, Table 2.1- Mortality of  salmonid fry treated as embryos with endocrine active chemicals 
Mortality (%) 
EXP 1 (Dimorphic)  EXP 2 (Dimorphic)  EXP 3 (Males)  EXP 4 (Females)  EXP 5 (Salmon) 
Embryo treatment  Hatch·  1"' Feed
b  Hatch·  1
st Feedb  Hatch·  1
st Feedb  Hatcha  1  st Feedb  Hatch·  1  st Feedb 
Un injected  17c  19c  17
c  19c  8  12  1  11  23  36 
Oil injected  3  22  18  45  56  56  5  20  26  46 
a,p'-DDE (mg/kg) 
1  42  44  3  13  27  57 
10  17  58*  8  22 
40  14*  29*  17  54*  55  62  8  28  10  23 
80  10*  38*  32  75**  47  47  3  29  30  50 
160  13*  71** 
chlordecone (mg/kg) 
7.5  27*  42* 
15  15*  51* 
30  22*  67** 
p,p-DDE (mg/kg) 
10  12  48 
40  11  44 
80  13  48 
DOE mix (mg/kg) 
10  15  74 
40  13  51 
80  8  55 
octylphenol (mg/kg) 
0.01  57  62  4  14 
0.1  68  69  5  8 
25  29  3  6 
·Mortality measured approximately 7 d post-hatch 
bMortality measured approximately 14 d after fish were fed for the first time 
CEstimated mortality in stock fish, based on observations from a single spawn; corresponds well with historic levels of  mortality in this partially 
inbred stock population (personal observation) 
*Higher mortality than oil injected controls of  the same experiment (p < 0.05) 
**Higher mortality than lower dose treatments and oil injected controls (p < 0.05) 5 
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Figure 2.1- Ratio of males females in response to embryonic o,p'-DDE exposure in rainbow trout, EXP I.  * denotes p < 005 in 80 
mg/kg (n=33) and  160 mg/kg (n= 15) treatments 46 
30 mg/kg, respectively), but the sex ratios were not statistically different than the control 
ratio of  1  :  1.  Similar experiments using rainbow trout (EXP 2) and chinook salmon (EXP 
5) failed to replicate the changes in sex ratio seen with o,p'-DDE in EXP 1.  Neither p,p'-
DDE, DDE mixtures, or octylphenol treatments altered sex ratios in trout or salmon. 
Monosex populations of  rainbow trout were also treated with o,p'-DDE and octylphenol 
and no sex reversal was observed.  All fish in EXP 3 were male and all fish in EXP 4 were 
female, regardless of  treatment. 
One pair of  unusual gonads was seen from a fish treated with 160 mg/kg o,p'-DDE 
in EXP 1.  These gonads were phenotypically female when examined grossly, but under 
light microscopy distinct male and female germ cells were apparent within each gonad 
(Figure 2.2).  Germ cells were not mixed throughout the gonad, rather two distinct 
portions of  the gonad exist, each containing cells indicative of  male or female gonads.  All 
other gonads were normal, in all experiments, containing either male or female 
organization and cells.  Histological examination confirmed that gross observations of 
sexual phenotype were correct for trout.  However, gross determination of  salmon sex 
often resulted in incorrectly scoring males as females.  Consequently, salmon sex ratios 
reflect only information obtained histologically. 
DDEs and chlordecone were successfully administered to eggs and persisted 
throughout the period of  sexual differentiation in developing fish.  The elimination of 
radio labeled [
14C]chlordecone and C
4C]p,p'-DDE from eggs provided estimates of  CD ty, 
of19 - 29 d (7.5 and 15 mglkg doses) andp,p'-DDE tyz of347 - 408 d (10 and 80 mg/kg 
doses).  DDE residues were also measured in fat samples taken from fish 283 dafter 
injection in EXP 2.  Mean residues were 0.033 and 0.15 ppm in 10 and 40 mglkg o,p'-47 
Figure 2.2 - Gonad of  six month old morphologic female rainbow trout treated with 160 
mg/kg o,p'-DDE in ovo (EXP 1). (Fop)  Gonad appears to have distinct female and male 
portions, with no apparent mixing of  germ cells except around the transition boundary 
shown here.  Closed arrow represents tear in gonad, probably not related to treatment. 
Open arrows show characteristic female gonad structure.  Large arrowhead indicates 
characteristic male gonad structure.  Small arrowheads show lamellae structures 
characteristic of  female gonads.  (8 x magnification).  (Bottom) High power view of 
transition point between female and male gonad structure.  Small arrowhead shows the 
distinct membrane characteristic of  female lamellae.  This appears to be a final lamellar 
structure, rather than a tear in the gonad, as characterized by the intact membrane. 
Number 1 shows a typical female germ cell at six months of  age.  Number 2 shows the 
typical cluster arrangement of  male germ cells at this stage of  development.  This is the 
only portion of  the gonad where male and female germ cells can be seen together.  (132 x 
magnification)  . Figure 2.2 Table 2.2 -DDE residues in fish approximately nine months after embryo 
exposures
3 
Embryo treatment  DDE Residue Analysis 
(% original dose)b 
Chemical  Dose (mg/kg)  o,l!'-DDE (~~~)  e.e'-DDE (~~~) 
Oil (vehicle)  BDL
c  BDL 
o,p'-DDE  10  6.5 ± 0.1  BDL 
40  3.8 ± 1.1  <2.6
d 
p,p'-DDE  10  BDL  78.3 ± 15.0 
40  <2.5
d  58 ± 6.8 
80  < 1.5
d  57 ± 14.5 
DDE mix
e  10  44.2 ±4.1  109 ± 1l.9 
40  16.6 ± 5.3  56.9 ±2.7 
80  7.6±2.0  58.8 ± 4.7 
3  Residue analysis was determined by GC-ECD after extraction from fat 
samples taken 283 d after egg injections. 
b  Values represent mean ± SEM of  six fish, with the exception of  10 mg/kg 
o,p'-DDE (n=2) and 40 mg/kgp,p'-DDE (n=5).  Percent of  original dose 
recovered was estimated based on 6.98% total body weight as fat in 
rainbow trout (42). 
C BDL = below detection limit (0.02 and 0.01 Jlg/g fat for o,p'- and p,p'-
DDE, respectively) 
d Isomer was detected in some samples 
e DDE mix was 5.4: 1 p,p'-DDE:o,p'-DDE 
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DDE treatments and 0.402, 1.4, and 2.7 ppm in 10,40, and 80 mg/kgp,p'-DDE 
treatments. Table 2.2 shows that both o,p'-DDE and p,p'-DDE were present in treated 
fish, but not in oil injected fish.  Detection limits were 0.02 and 0.01  J.1g/g fat for o,p'-DDE 
and p,p'-DDE, respectively.  Total body burden ofDDE isomers was estimated based on 
the fact that approximately 6.98% of  total body weight is fat in juvenile rainbow trout 
(42).  Residues ofp,p'-DDE predicted by t'h after 283 d were  61.3% and 72.1%, for low 
and high doses, which were similar to the observed levels of78.3% and 57% of  the 
original dose (Table 2.2).  We found that p,p'-DDE was more persistent in fish than o,p'-
DDE, which, coupled with greater amounts of  p,p'- isomers produced in technical 
mixtures, likely contributes to higher environmental levels of  p,p'-DDE. 
Treatment with these known and putative xenoestrogens did not alter in vitro 
steroid production by gonads in a dose-dependent manner in any experiments.  However, 
gonadal steroid production proved to be sensitive to embryonic manipulation, as 
evidenced by decreased androgen production (testosterone and ll-ketotestosterone) by 
gonads from male fish injected with chemicals or vehicle in EXP 3, compared to 
uninjected controls (p < 0.05; data not shown). 
Subsets offish from EXP 2 and EXP 3 were reared for 2-2'l'2 years until normal 
sexual maturation would occur.  At least ten fish from each treatment were examined 
grossly and all fish had normal gonads.  Ripe males and females from EXP 2 spawned 
successfully with control fish.  Fertilization success was virtually 100% and most eggs 
survived until well developed embryos were visible within eggs (14 DPF).  Between 14 
DPF and 21  DPF embryo development was monitored by observing the size and intensity 
of  eye pigments. shortly after which hatch occurred (24-25 DPF in 13°C water). 51 
Mortality increased between 14-21 DPF, and hatch was delayed 1-3 d, in various eggs 
spawned from xenoestrogen exposed mothers (personal observation).  Survival of  progeny 
from males was greater than females, though survival did not correlate with in ovo 
toxicant exposure (Table 2.3).  No treatment dependent differences in female GSI or egg 
production were observed.  Crosses of  in ovo exposed males and females also developed 
and hatched successfully (data not shown).  While these data do not represent a 
comprehensive study of  reproductive effects on population dynamics, they show that 
treated fish were maturing normally. Table 2.3 - Reproductive perfonnance in trout exposed as embryos to DDE 
isomers
a 
Embryo treatment (PI)  FI  Survival (%)b 
Chemical  Dose (mg/kg)  PI Male (n)  PI  Female (n) 
Untreated 
Oil (vehicle) 
o,p'-DDE 
p,p'-DDE 
DDEmix
e 
10 
40 
80 
10 
40 
80 
10 
40 
80 
88 (2)  44
c (2) 
76 (1)  ND
d 
72 (1)  71  (1) 
85 (2)  ND 
82 (2)  33 (1) 
82 (2)  35 (3) 
77 (1)  24
c (2) 
69 (1)  47 (1) 
87 (2)  54 (1) 
94 (1)  10 (2) 
78 (2)  ND 
a Trout injected with chemicals as embryos were reared to maturity.  Treated 
fish were crossed with untreated, stock fish and embryo survival was 
monitored.  Gonads were examined grossly and were normal in all fish. 
b Survival is represented as mean of  offspring that survived until one week 
after hatch.  Small samples prevented meaningful standard error calculations 
c Denotes eggs from one female failed to hatch after successful fertilization 
d ND - not determined 
e DDE mix was 5.4:1 p,p'-DDE:o,p'-DDE 
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Discussion 
Doses of  o,p'-DDE and CD that had little effect on trout fry and juveniles were 
lethal to embryos and yolk-sac fry.  Lethality varied little between 4d and 14d in fry 
injected ip, suggesting that absorption of  toxicants did not increase appreciably after four 
days.  Embryos were injected with DDEs, CD, and octylphenol at maximally tolerable 
doses which are not likely to occur in nature, except perhaps at highly contaminated sites. 
The finding that developing embryos were more susceptible to toxicants than older fish 
was not surprising and suggest that maternal transfer of  chemicals from females living in 
heavily contaminated waters could affect embryo survival and local fish populations. 
Microinjection of  eggs with vehicle alone had two unintended consequences. 
Injection of  eggs decreased time to hatch in both trout and salmon (personal observation), 
which may increase background mortality rates.  Oil injected control mortality in our 
experiments were not higher than historical levels or comparable uninjected controls 
except in EXP 2 and EXP 3.  In those experiments, increases in mortality may have been 
due to injections altering development or simply to genetic variations in brood fish (EXP 
2) or genetically manipulated offspring (EXP 3).  Injection with oil or chemicals also 
caused a decrease in androgen production by males in EXP 3.  Male gonads incubated six 
months after exposure produced approximately 50% less testosterone and 11-
keto  testosterone than uninjected fish.  No differences were seen between treatment groups 
or oil injected controls, suggesting an association with injection itself.  Thin layer 
chromatography on menhaden oil revealed few components other than triacylglycerides 
and appeared identical in composition to a canola oil control.  Changes in steroid 54 
production could be a result of  an unidentified contaminant or steroid in the oil vehicle, 
altered development due to injection, or a stress response due to egg manipulation. 
Topical application of  toxicants in DMSO resulted in approximately 30% incorporation 
into eggs (unpublished data) and while absorption was lower than injection, this may be a 
less stressful dosing technique (43). 
There are no obvious explanations why sex ratios were affected in EXP 1 but not 
in other experiments.  Fish came from different spawns and light cycle (natural vs.  12 h 
light:dark) and water temperature (12 - 14°C range) may have varied slightly, but those 
conditions varied between unaffected treatments (EXP 2-4) as well.  Mortality rates may 
have been higher in females than males in EXP 1, but similar results should have been 
noted in EXP 2.  Unfortunately, attempts to compare mortality in all male (EXP 3) and all 
female (EXP 4) treatments were confounded by high background mortality rates (approx. 
50% in males, 80-90% in females) prior to experimental treatment, due to genetic 
manipulation of  fish. 
Histological observation of  male and female germ cells in one of  two fish examined 
from 160 mg/kg o,p'-DDE exposure in EXP 1 is compelling evidence that trout are 
susceptible to xenoestrogen treatment.  Observations of  unusual gonads in rainbow trout 
exposed to OH-PCBs (44) and 17J3-estradiol (30) support our assumption that gonadal 
abnormalities were due to chemical treatment.  We examined gonads from hundreds of 
fish and while morphological variability was common, we never observed other gonads 
with both male and female germ cells, suggesting that our observations were not due to 
random genetic variation.  Because 160 mg/kg o,p'-DDE treatment was acutely toxic to 
embryos and is unlikely to be observed in natural waters, we did not repeat studies using 55 
that dose.  It is possible that a threshold for gonadal abnormalities is above all other doses 
used in our experiments. 
It should be considered that injected chemicals were sequestered away from target 
tissues or somehow metabolized and cleared from fish.  We did not include estrogen 
treatments as positive controls because trout embryos have the ability to metabolize and 
excrete exogenously administered estrogens within 24 h (45), rendering short term 
estrogen exposure ineffective at feminizing trout.  Evidence from radiochemical studies 
and residue analyses confirmed that DDEs and chlordecone were present in fish 
throughout the period of  sexual differentiation.  No residue analysis of  octylphenol was 
performed, but its lipophilic nature suggests a long half-life in fish (46).  Additionally, 
injection occurred 21  days after fertilization, subsequent to organogenesis and the most 
sensitive stages of  embryo development.  Chemicals could potentially alter sexual 
development prior to this life stage, but sexual differentiation in salmonids is not complete 
prior to exposure periods tested (24,29,30). 
Normal gonadal steroid production in vitro suggested that normal sexual 
development was occurring in immature fish.  Fitzpatrick et al. (30) observed decreased in 
vitro steroid production injuvenile trout fed 17J3-estradiol and methyltestosterone, 
suggesting that abnormal development of  gonads in our studies would have produced 
anomalous steroid profiles.  Sex steroid production in fish increases during maturation 
and, similar to humans, exposure to hormones during development can result in sexual 
abnormalities that are not apparent until maturation (24).  Fish appeared to mature 
normally and no sexual or reproductive abnormalities were observed in mature males or 56 
females.  Gametes from a subset of  males and females from EXP 2 crossed with either 
control fish or other treated fish resulted in viable offspring.  Genetic variability plays a 
large role in reproductive success, as evidenced by the failure of  all crosses with one of 
two female stock fish.  Consequently, quantitative measurements of  egg viability in treated 
females were impossible.  Nevertheless, the majority of  evidence suggests that all fish 
treated as embryos were maturing normally. 
Significant abnormalities in sexual development were only seen in rainbow trout in 
one experiment with o,p'-DDE, an estrogenic metabolite of  DDT.  Embryonic exposure of 
trout to p,p'-DDE, DOE mixtures, chlordecone. and octylphenol failed to alter any of  the 
parameters of  sexual development tested.  A single experiment with o,p'-DDE in chinook 
salmon, a species sensitive to complete feminization, also failed to cause developmental 
abnormalities.  Our conclusions are consistent with a recent report that p,p'-DDE failed to 
alter sex differentiation in a marine turtle (47).  With the exception of  heavily 
contaminated sites (2  J, 48), environmental residues are unlikely to approach levels that 
would expose fish to doses used in this study.  Such contamination, if  present, would 
probably alter fish populations due to lethality prior to exerting more subtle endocrine 
disrupting effects.  While salmonid fishes are advantageous models for biomedical 
research, long life spans and low sensitivity to environment levels ofEACs point to 
aquarium fish as better models for multigenerational endocrine toxicity studies.  We 
cannot dismiss the potential hazards of  complex mixtures or variations due to species 
differences, but we can conclude that average environmental levels of  the chemicals tested 
are unlikely to have profound effects on endocrine development in salmonids. 57 
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Abstract 
Many natural and synthetic xenobiotics are known to interact with endocrine 
systems of  animals.  Various hydroxylated metabolites of  persistent polychlorinated 
biphenyl contaminants (OH-PCBs) have been shown to have agonist or antagonist 
interactions with estrogen receptors.  In this study, 4-hydroxy-2',4',6'-trichlorobiphenyl 
(OH-PCB 30) and 4-hydroxy-2',3',4',5'-tetrachlorobiphenyl (OH-PCB 61), and the natural 
estrogens 17~-estradiol (E2)  and estrone (EI)' were incorporated into diet and fed to 
juvenile rainbow trout.  The production of  vitellogenin (V  g), an egg yolk protein 
precursor in oviparous animals, was used as a marker of  hepatic estrogen receptor 
binding.  All compounds induced plasma Vg in a dose-dependent manner, with maximal 
levels of  approximately 5 mg V  g/ml plasma induced by E2,  EJ, and OH-PCB 30. 
Maximum plasma Vg of  48 ~g/ml in the highest dose (50 mg/kg) ofOH-PCB 61  was 
approximately lOO-fold lower than natural estrogens and OH-PCB 30.  At doses that 
induced sub-maximal Vg, EI was 2 to 3-fold less potent, and OH-PCB potencies were up 
to 500 fold less potent, than E2•  Predictions from previous receptor binding studies 
underestimated the maximum estrogenic response ofOH-PCB 30 in trout, which was 
achieved with a dose 10 times higher than E2•  Differences in plasma Vg induction by OH-
PCB 30 and OH-PCB 61  support in vitro predictions that the degree and position of 
chlorination are important for estrogen receptor activation.  Cotreatment with mixtures of 
E2 and EI or OH-PCB 30 and OH-PCB 61  resulted in Vg levels predicted by an additive 
mechanism of  hepatic estrogen receptor binding.  Age offish did not appear to influence responsiveness to estrogenic mixtures.  Sex differences in V  g synthesis were apparent at 
weakly estrogenic doses, but were not evident at maximal Vg inducing doses. 
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Introduction 
Polychlorinated biphenyls (PCB) are persistent organic pollutants which have 
contributed to historical declines of  fish and wildlife populations.  While the manufacture 
and use of  PCBs in the United States was banned two decades ago, residual contamination 
continues, particularly in the Great Lakes region (1,2).  PCBs bioaccumulate in anima1s 
and residues are prevalent in humans, fish, and wildlife (3-7).  PCBs have been shown to 
alter mixed function oxidase systems (8), potentially affecting steroid metabolism (9). 
Reproductive, thyroid and immune dysfunction from PCB exposure have also been 
observed (1,10-12), which are thought to be due to receptor binding of  PCBs as structural 
analogs of  dioxin, thyroxin, and estrogens (13,14).  PCBs have been implicated in learning 
and memory deficits in children exposed in utero and through contaminated breast milk 
(15), but adverse health effects in adults have not been demonstrated conclusively (16). 
Highly chlorinated PCBs tend to be the most persistent congeners in the environment, but 
OR-PCB metabolites have been shown to persist in animals and the bioavailability of 
lower chlorinated PCBs may be greater than highly chlorinated congeners (3,8). 
Rydroxylated metabolites of  PCBs (OR-PCBs) are able to interact with estrogen 
receptors (ER) in vitro, which can result in either estrogenic or antiestrogenic activity (17-
19).  The estrogenicity ofOH-PCBs has been established in vivo as well, resulting in 
alterations in sex differentiation in turtles (20) and increased uterine weight in mice (21). 
Unusual results seen with mixtures oJ  OR-PCBs and other xenoestrogens in vivo have 
suggested that chemicals may act synergistically to induce estrogenic responses (20,22). 
"------------------------------------A recent report by Ramamoorthy et al. (21), however, documented additive estrogenic 
responses of  mixtures ofOH-PCBs in vitro and in mice. 
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The estrogenic activity ofOH-PCBs in vivo, particularly mixtures, have not been 
well characterized.  The studies described here were designed to determine whether two 
OH-PCBs are estrogenic in rainbow trout exposed in vivo.  4-Hydroxy-2',4',6'-trichloro-
biphenyl (OH-PCB 30) and 4-hydroxy-2',3',4',5'-tetrachlorobiphenyl (OH-PCB 61) are 
estrogenic in vitro (17,21) and in turtles (20), but their activity in fish has not been 
examined.  Induction ofvitellogenin (Vg), a phospholipoglycoprotein egg yolk: precursor 
produced in oviparous animals, has been used as a marker of  hepatic estrogen receptor 
binding in fish (22-24).  Vg is not present in appreciable amounts in immature fish, so 
induction by estrogenic chemicals is easily detected.  We fed juvenile rainbow trout, 
Oncorhynchus mykiss, varying doses of  the natural estrogens 17p-estradiol (E2)  and 
estrone (E1)  and compared their ability to induce vitellogenin synthesis with that of  various 
PCBs, OH-PCB 30 and OH-PCB 61.  Trout were also fed mixtures of  estrogens and OH-
PCBs to determine whether V  g levels increased in a manner suggestive of  additive ER 
binding. 68 
Materials and Methods 
Chemicals 
The following PCBs and OH-PCBs, 100% pure, were purchased from 
AccuStandard (New Haven, CT):  4-hydroxy-2',4',6'-trichlorobiphenyl (OH-PCB 30); 4-
hydroxy-2',3',4',5'-tetrachlorobiphenyl (OH-PCB 61); 2,4,6-trichlorobiphenyl (PCB 30); 
2,3,4,5-tetrachlorobiphenyl (PCB 61); 2,4,4',6-tetrachlorobiphenyl (PCB 75); and, 
2,3,4,4',5-pentachlorobiphenyl (PCB 114).  The natural estrogens 17~-estradiol (E2) 
(minimum 98% pure) and estrone (E1)  (>99% pure) were purchased from Sigma Chemical 
Co. (St. Louis, MO).  All other chemicals were of  reagent grade or better and purchased 
from Sigma unless noted. 
Experimental Design 
Immature rainbow trout were reared and treated at the MarinelFreshwater 
Biomedical Sciences Center at Oregon State University, with IACUC approval.  Fish were 
maintained in 3' diameter tanks with continuously running, 12-14°C well water, with a 
density of  eight fish per tank.  Estrogens, OH-PCBs and PCBs were dissolved in DMSO 
(0.1 % v/w in diet) and mixed into a semi-purified trout diet, OID (25). Trout were fed a 
growth ration of  4% diet per day (w/w) for 7 d and euthanized on day 8, unless noted, in 
four separate exposure periods.  Experiment 1 (EXP 1):  An initial experiment to 
determine doses of  natural estrogens and OH-PCBs that induce vitellogenin in a mixed sex 
population of  trout.  Fish were sexually immature, approximately 12 months old.  Eight 
fish per treatment were fed 0.05, 0.5, 5, 12.5 mg/kg E2 or E\, or 0.01,0.1, 1, 10,25,50 69 
mg/kg OH-PCB 30 or OH-PCB 61.  Experiment 2 (EXP 2): PCB congeners, lacking a 
hydroxyl group, were tested for estrogenic potential in vivo.  Eighteen month old juveniles 
of  both sexes (n=6), were fed for 5 d and killed on day 7, after fasting for one day.  Diets 
contained 50 mg/kg of  PCB 30, PCB 61, PCB 75, or PCB 114.  Plasma was assayed for 
V  g.  Experiment 3 (EXP 3):  The estrogenicity of  mixtures of  natural estrogens and OH-
PCBs was explored.  Genetically male trout (n=5) were produced by fertilizing stock eggs 
from a single female with sperm containing only Y chromosomes (milt provided by Gary 
Thorgaard, Washington State University).  Approximately 2 year old fish were fed 
mixtures designed to include a dose of  chemical near the threshold for V  g induction, 
determined from EXP 1, with an additional chemical increasing in dose from low to 
average Vg inducing capability.  The natural estrogens E2 and E 1, which occur 
physiologically as mixtures, were fed in diet containing 0.1  mg/kg E2 plus 0,0.05,0.5,2, 
or 5 mg/kg E1•  EI  was also fed alone at 0.5 mg/kg.  Mixtures ofOH-PCBs included 10 
mg/kg OH-PCB 30 plus 0, 1, or 10 mg/kg OH-PCB 61  and constant 10 rn!¥kg OH-PCB 
61  plus 0,0.1, or 1 mg/kg OH-PCB 30.  Experiment 4 (EXP 4):  In order to determine 
whether the age of  fish is important in the activity of  estrogenic mixtures, selected 
mixtures were fed to 6 month old trout fry (3 - 10 g).  Twelve fish per treatment were fed 
diet containing DMSO (0.1%), 0.1 mg/kg E2, 0.5 mg/kg EJ, 10 mg/kg OH-PCB 30, 10 
mg/kg OH-PCB 61, 0.1  mg/kg E2 + 0.5 mg/kg EI or 10 mg/kg OH-PCB 30 + 10 mg/kg 
OH-PCB 61.  Liver Vg was determined, rather than blood, because ofsmal1 circulating 
blood volume.  Sex ratios varied between treatments, so only livers from four males per 
treatment were analyzed.  Individual liver V  g levels were adjusted to total liver protein 
content (26). 70 
Vitellogenin analysis 
Vitellogenin concentrations were determined in blood for EXP 1, EXP 2, and EXP 
3, and liver in EXP 4.  Fish were collected and deeply anesthetized in 
tricainemethanesulfonate (MS222 50 mgfL), blood was drawn from the caudal vein in 
heparinized syringes or vacutainers, and fish were killed by severing the spinal cord.  A 
mixture ofaprotinin (150 kallikrein in1nbiting units) and EDTA (ImM in 0.02% Tris, pH 
8) was added to whole blood to prevent proteolysis of  V g.  Blood was kept on ice until 
centrifugation at 3000 g for 10 min.  Livers were removed (EXP 4 only), snap frozen in 
liquid nitrogen and held at -80°C until homogenization in 4 volumes (v/w) of  buffer (0.1 
M tris-acetate, 0.1 M KCl, 1 mM EDT  A, 0.1  mM butylated hydroxytoluene (BHT), and 
0.1  mM phenylmethylsulfonyl fluoride (PMSF), pH 7.4).  A competitive enzyme-linked 
immunosorbent assay (ELISA) for Vg was modified from Donohoe and Curtis (23) and 
described elsewhere (27).  Purified rainbow trout vitellogenin and IgG raised against chum 
salmon Vg were obtained from D.R. Buhler, Oregon State University (antibody originally 
isolated by A. Hara, Hokkaido University).  Cross reactivity of  anti-salmon IgG was 
confirmed by visualization of  proteins separated by SDSIP  AGE and analyzed by western 
blotting.  There was no evidence of  non-specific antibody binding to either microtiter 
plates or proteins.  Intraassay variability was less than 10% and interassay variability less 
than 15%.  V  g levels are presented as mean ± SEM for each treatment group.  Mean V  g 
levels were compared statistically by ANOV  A, followed by Fisher's PLSD between 
treatments and Student's t-tests between sexes within individual treatments. 71 
Results 
The hydroxylated PCBs investigated proved to be estrogenic in rainbow trout in 
vivo.  One week of  dietary exposure to natural estrogens or OH-PCBs was sufficient to 
induce vitellogenin production in immature trout.  Plasma V g increased in a dose-
dependent manner with increasing doses of  natural estrogens or OH-PCBs (Fig. 3.1).  Vg 
reached a maximum level of  approximately 5 mg/ml in plasma in E2, E\, and OH-PCB 30 
treated fish.  Increasing the dose of  estrogens beyond 5 mg/kg did not increase plasma V g 
(Fig. 3.1).  The maximum plasma Vg induced by OH-PCB 61  was 48 ± 16 ~glm1, which 
was approximately 100 fold lower than E2,  E\, or OH-PCB 30.  Baseline plasma Vg from 
male and female pools was 1.2 ± 0.8 ~glml, with a detection limit of  approximately 62 -
125 nglml (depending on individual ELISA standard curves). 
Male fish consistently produced less V g than females, when fed weakly estrogenic 
doses.  Statistical analyses were complicated by unequal sex ratios in many treatments, but 
males in 0.05 mg/kg E2,  0.1 mg/kg E\ and 25 mg/kg OH-PCB 61  doses had significantly 
lower plasma V  g than females (p<0.05).  At doses of  chemicals that induced plasma V  g to 
mglmllevels, which were approaching the maximal observed V g of  5 mg/ml, males and 
females produced equivalent amounts of  protein.  Female controls usually had basal Vg 
concentrations above detection limits, while V g was undetectable in males in the absence 
of  estrogenic treatments. 
PCBs lacking hydroxylation in the para position did not induce V g production. 
Neither PCBs lacking substitution in the para position (PCBs 30 and 61) nor 72 
Figure 3.1- Plasma vitellogenin (Vg) in twelve month old mixed sex trout after dietary 
exposure to estrogens and OH-PCBs.  Values represent mean ± SEM (n=5-8).  *indicates 
significantly greater than control diets (1.2 ± .8  ~g  Vg/ml); P < 0.05.  (a) E2 (solid bars) 
and E1(open bars).  (b) OR-PCB 30 (solid bars) and OH-PCB 61  (open bars).  n.b. 
females produced more V  g than males at sub-maximal V  g inducing doses, so sex ratio 
influenced statistical analyses. 73 
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Figure 3.1 containing a Cl substitution (PCBs 75 and 114) in place of  the OH group induced Vg 
(Table 3.1).  The data suggest that non-hydroxylated PCBs were unable to activate 
estrogen receptors. 
74 
Fish from a population of  genetic males were responsive to V  g induction by 
mixtures of  estrogens and OH-PCBs (Figs. 3.2 and 3.3).  Vg was not detected in plasma 
of  untreated fish (detection limit of62 ng/ml).  Mixtures of  chemicals induced Vg 
production in a manner suggestive of  additive estrogen receptor activation.  Doses ofE2 
and OH-PCB 30 that were kept constant in respective mixtures induced V  g to 40 ± 20 
and 57 ± 28 f..lg/ml, which were approximately 100 fold lower than saturated levels seen in 
EXP 1.  The 10 mg/kg OH-PCB 61  dose appeared to be below the threshold for Vg 
induction in all male fish because only the OH-PCB 61  + 10 mg/kg OH-PCB 30 treatment 
induced Vg (Fig. 3.3).  Unfortunately, the diet containing only OH-PCB 61  was ruined 
during preparation so there were no fish fed OH-PCB 61  alone.  When Vg levels from 
males exposed to mixtures were compared to those in males from comparable mixed sex 
treatments (EXP 1), genetically manipulated males from EXP 3 consistently produced less 
Vg. 
Observations in six month old fry were similar to those in older juveniles. 
Mixtures of  estrogens and OH-PCBs induced liver V  g in males, while V  g was not 
detected in untreated fish.  Small livers and proportionally small homogenization volumes 
required the dilution of  samples 100 fold before assaying, resulting in a detection limit of 
1.25 f..lg/mlliver homogenate.  Vg was measurable in all treatments except controls, 0.1 
mg/kg E2, and 10 mg/kg OH-PCB 61.  After V  g was adjusted to total liver protein 
content, mixtures were compared to individual chemical treatments and V  g levels could be 75 
explained by classical, additive activation of  estrogen receptors (Fig. 3.4).  One puzzling 
observation was that Vg in fish fed a mixture ofE2 and EI  was significantly lower than fish 
fed EI  alone (p<O.05). 76 
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Figure 3.2- Vitellogenin induction in two year old male trout by mixtures of  natural 
estrogens.  Values are mean ± SEM from all male trout (n=5).  Varying doses ofEt were 
added to a constant dose of  0.1  mg/kg E2.  Vg was detected in only two of 10 control fish. 
* indicates significantly greater than E2 diet alone (p<0.05). a.b.c  indicate significantly 
different from each other (p<0.05). 77 
Figure 3.3- Plasma vitellogenin induction in two year old male trout in response to 
mixtures ofOH-PCBs.  Values are mean ± SEM from all male trout (n=5).  Vg was 
detected in only two of  10 control fish.  (a) Constant dose of 10 mg/kg OH-PCB 30 with 
varying OH-PCB 61  doses.  (b) Constant dose of  10 mg/kg OH-PCB 61  with varying OH-
PCB 30 doses.  aValue for 10 mg/kg OH-PCB 61  alone represents male fish from EXP1; 
no 10 mg/kg OH-PCB 61  data in all male fish was available, due to a problem with diet 
preparation. 78 
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Figure 3.4- Liver vitellogenin in six month old fish fed mixtures of  estrogens and OH-
PCBs.  Values are mean ± SEM from male trout (n=4).  Vg was not detected in control 
fish.  Doses were 0.1  mg/kg E2, 0.5 mg/kg E1,  10 mg/kg OH-PCB 30, and 10 mglkg OH-
PCB 61. or simple mixtures ofE2 and EI  or OH-PCBs.  *significantly lower than EI  alone 
(p<0.05). Table 3.1- Maximum estrogenicity of  PCBs in vivo, relative to natural estrogens 
E2 
E) 
OH-PCB 30 
OH-PCB 61 
PCB 30 
PCB 61 
PCB 75 
PCB 114 
Max. V  g (mg/m1t 
4.5 
4.7 
4.5 
0.048 
d 
Dose (mg/kg)b 
5 
5 
50 
50 
50 
50 
50 
50 
3Maximum plasma vitellogenin (Vg) induced (i.e. "efficacy") 
~ose  necessary for maximum V g (i.e. "potency") 
Estrogenicitt 
1 
1 
0.1 
0.001 
o 
o 
o 
o 
cRelative maximum estrogenicity compared to E2 and E), detennined as:  efficacy-) x 
potencf) (n.b. relative estrogenicity varies for sub-maximal doses) 
dpCBs lacking OH moiety did not induce V g in males or females 
80 81 
Discussion 
Dietary exposure to natural estrogens and OR-PCBs resulted in dose-dependent 
induction of  plasma vitellogenin in immature trout.  Fish were responsive to V  g induction 
by both OR-PCB 30 and OR-PCB 61, with the di-ortho substituted OR-PCB 30 having 
higher potency and 100-fold higher maximum Vg than the mono-ortho congener.  Korach 
et al. (17) examined the ability of  various OR-PCBs to bind to mouse uterine estrogen 
receptors in vitro and found that ortho substitution on the nonphenolic ring conferred the 
greatest ER binding.  The ER binding activity of  OR-PCB 61  was approximately 100-fold 
lower than E2  in mice (17), which was similar to the difference in maximal V  g induction 
seen here.  Surprisingly, maximal Vg induction by OR-PCB 30 was equivalent to the 
natural estrogens E2 and E1.  Estrogenic potency of  OR-PCB 30 was lower than E2, with 
maximal V g induced at 50 mg/kg, compared to 5 mg/kg for E2.  A 10 mg/kg dose of  OR-
PCB 30 resuhed in plasma V  g of  680 Jlg/ml, which was 7 fold lower than corresponding 
E2 and E1  doses.  The threshold for Vg induction was between 1-10 mg/kg OR-PCB 30, 
which was 20-200 times higher than 0.05 mg/kg E2 or E1  doses that significantly induced 
Vg.  Receptor binding studies showed that ER affinity of  OR-PCB 30 was approximately 
40-fold lower than E2 (17), which probably contributed to the lower potency of  OR-PCB 
30.  The threshold for Vg induction for OR-PCB 61  was between 10-25 mg/kg. 
It was interesting to find that lower V  g inducing potencies did not prevent E1  and 
OH-PCB 30 from inducing Vg to the maximum seen with E2.  Both E2 and E1  induced Vg 
at all doses tested, but E1  was 2-3 times less potent than E2 at doses that induced sub-
maximal Vg levels.  The potency differences between E2 and E1  were similar to the 2-5 82 
fold difference in potency in trout exposed to estrogens in water (28).  E2 is the major 
circulating hormone in fish (29) and fish may be more sensitive to E2 than other natural 
estrogens, such as E\.  While in vitro predictions for ER binding by OH-PCBs correlated 
well with the potency differences we observed, maximal V g induction in vivo did not 
appear to be simply a function of  receptor affinity.  Evidence from studies with the 
xenoestrogen octylphenol in mice and trout were similar to these data, showing that in 
vivo estrogenicity was higher than what was predicted from in vitro studies (28,30). 
Estrogenicity ofE\ and OH-PCBs in vivo was estimated based on dose, relative to E2, that 
resulted in maximum plasma Vg (Table 3.1).  The relative estrogenicity ofOH-PCB 30 
was thus estimated to be 10% of  the natural estrogens.  For OH-PCB 61, which did not 
induce V  g to maximal levels, the dose relative to E2 was divided by 100, resulting in an 
estimate of  1000 fold lower in vivo estrogenicity (Table 3.1).  The maximum V  g inducing 
treatment ofOH-PCB 61  contained six males and only one female, so maximum induction 
by female fish may be higher than the data shown. 
Estrogen receptors in trout liver are auto  induced by estrogen or xenoestrogen 
exposure (23,31), which probably contributed to the equivalent maximum Vg levels seen 
in OR-PCB 30 and estrogen treated fish.  While we did not directly measure estrogen 
receptor expression, V  g production is thought to be mediated solely through estrogen 
receptor mediated transcription (24).  Donohoe and Curtis (23) also showed that ER 
binding sites, as well as V g, increased in immature rainbow trout injected ip with the 
xenoestrogens o,p'-DDT, o,p'-DDE, and chlordecone.  The existence of  a maximum level 
of  plasma Vg observed in these experiments suggests that hepatic estrogen receptors were 
saturated, which is consistent with other studies in trout in vitro (31) and in vivo (28).  We 83 
have tested a variety of  chemicals for in vivo estrogenicity and each chemical was found to 
have a particular maximum capacity for V  g induction, which were not all equal to natural 
estrogens (32 and unpublished data).  The fact that OH-PCB 30 and E\ had lower potency 
but equivalent maximum V g induction compared to E2 suggests that the number of 
available estrogen receptors, in conjunction with chemical ER affinity, played a role in the 
regulation of  estrogenic chemicals in vivo.  PCBs and OH-PCBs bioaccumulate in fish 
tissues, which has been proposed to increase in vivo estrogenicity of  octylphenol in trout 
through prolonged ER interactions (28). 
Vitellogenin was not induced by PCBs lacking an OH moiety, which suggests that 
PCBs were not readily metabolized in trout and that the native PCBs tested do not bind to 
estrogen receptors.  The phenol rings in OH-PCBs are thought to bind to the active site of 
ER (17), and our results confirm that hydroxylation is necessary to confer receptor 
activation.  Chlorination on the nonphenolic rings of  the four PCBs tested were identical 
to the OH-PCBs tested. with structural differences involving only the phenol ring.  PCBs 
30 and 61  simply lacked hydroxylation in the para position of  the "phenol" ring, while 
PCBs 75 and 114 contained a CI substitution in the para position.  Lack ofVg induction 
by PCBs showed that ortho chlorination on the nonphenolic ring was not sufficient to 
activate liver ER, supporting the prediction that phenol rings mediate ER binding. 
Additive estrogen receptor binding is a possible explanation of  plasma V g levels 
observed after dietary exposure to mixtures of  natural estrogens and OH-PCBs.  The 
constant doses ofE2, OH-PCB 30, and OH-PCB 61  were chosen to be below maximal, 
and close to threshold, Vg inducing doses. Increasing amounts ofEI mixed with constant 
E2 resulted in a dose-dependent increase in V g, above the levels induced by E2 alone.  The 84 
addition oflow potency doses ofOH-PCB 61  to constant OH-PCB 30 did not affect Vg 
levels and only the 10 mg/kg OH-PCB 30 dose mixed with constant PCB 61  induced Vg 
above background.  Doses with low estrogenic potency were chosen for mixture studies, 
allowing for large increases in V  g before plasma V  g levels were saturated. If  chemical 
mixtures enhanced liver ER binding in a synergistic manner, we should have observed 
higher plasma V g levels. 
Sexes responded differently to weakly estrogenic doses, evidenced by higher 
plasma V  g induced in females than males.  Small initial sample sizes prevented robust 
statistical power, but differences were significant in three doses.  Differences between 
sexes have been supported by subsequent work in our lab (27).  In order to reduce 
variability, we used fish from a population of  all male trout, produced by crossing normal 
females with sperm containing only Y chromosomes, for experiments involving mixtures 
(EXP 3).  Plasma Vg was consistently lower than levels in male fish from the initial study 
(EXP 1), so we were unable to directly compare V  g levels in similarly treated fish from 
the different studies.  Trout from our facilities are partially inbred (Shasta strain) but 
vitellogenin levels varied up to 100 fold between individual fish of  the same sex, which 
was consistent with other observations in salmonids (28,33).  Trout from the genetic male 
population were approximately one year older than stock fish (EXP 1), but age does not 
seem to influence Vg production in male fish (27).  It is not clear whether estrogen 
responsiveness was inherently different in genetically manipulated fish or if  V  g differences 
were simply due to natural variation.  Nevertheless, there was no evidence of  synergism 
between the natural or xenoestrogen mixtures tested in all male trout. 85 
Many fish are sensitive to hormone treatment during a specific window of 
development.  Sexual differentiation of  rainbow trout and other salmonids can be 
manipulated by hormone treatment, resulting in partial or complete sex inversion (34-36). 
We hypothesized that estrogen receptor regulation may be different in trout during the 
period of  greatest sensitivity to steroid hormones.  To test this hypothesis, we treated six 
month old fish with simple mixtures ofOH-PCBs and natural estrogens.  Sexual 
differentiation had likely occurred by six months, but trout cannot be easily sexed before 
that time.  Liver vitellogenin levels were estimated and results were similar to those in 
older fish.  E2, E"  and OH-PCB 30 induced Vg at the doses tested, while data from 
chemical mixtures suggested additive (or competitive) binding of  estrogen receptors.  The 
only unusual result was that treatment with a mixture ofE2 and E, resulted in significantly 
lower liver Vg than E, alone (E2 dose was below the response threshold).  One 
explanation for this observation could be competition for ER binding sites.  In older fish, 
E2 was 2-3 times more potent than E"  while the dose ofE, in this study was 5 times 
greater than E2.  E2 may have bound to a percentage of  available receptors without 
inducing V g gene transcription, but there is no evidence in the literature or within our data 
to suggest this was the case.  We did not perform a comprehensive investigation ofthe 
effects of  estrogen mixtures during trout sexual development, a period which may be most 
sensitive to xenoestrogens, but our results were consistent with simple models of  estrogen 
receptor interaction with mixtures of  ligands. 
One week of  dietary exposure to natural estrogens and OH-PCBs was sufficient to 
induce Vg in immature rainbow trout.  We did not determine the residence time ofVg in 
plasma, but it would be interesting to see if  V g clearance time is similar in estrogen and 86 
OH-PCB treated fish.  OH-PCBs may persist in trout after short term exposures, which 
could result in prolonged ER stimulation and elevated plasma Vg levels compared to 
treatment with estrogens, which are readily metabolized.  Our data in fish confirm earlier 
reports of  the estrogenicity ofOH-PCB 30 and OH-PCB 61  in other animals.  These 
results suggest that fish may be sensitive to other estrogenic metabolites of  PCBs and that 
persistent xenoestrogens may have higher relative potency in vivo than predicted from in 
vitro studies.  There was no evidence to suggest synergism of  either natural estrogens or 
OH-PCBs with respect to estrogen receptor dependent vitellogenin induction. 87 
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Chapter 4 
Tamoxifen Antagonizes Changes in Cytochromes P450 and Vitellogenin Mediated 
by 17p-Estradiol in Rainbow Trout 
David B. Carlson, Cristobal L. Miranda, Donald R. Buhler, and David E. Williams 
Department of  Environmental and Molecular Toxicology and MarinelFreshwater 
Biomedical Sciences Center, Oregon State University, Corvallis, OR 93 
Abstract 
Many environmental chemicals have been found to interact with endocrine systems 
of  animals.  The expression and activity of  enzymes active in steroid and xenobiotic 
metabolism, such as cytochromes P450 (CYP), are potential endpoints for endocrine 
disruption.  Natural estrogens are known to decrease CYP expression in fish, but it is not 
known whether estrogen receptors are involved.  Tamoxifen, a tissue-specific estrogen 
receptor agonist, 17j3-estradiol (E2), and mixtures of  the two were fed to immature 
rainbow trout, Oncorhynchus myldss, in order to investigate mechanisms of  endocrine 
modulation.  Vitellogenin (V  g) induction was used as a biomarker of  estrogen receptor 
activation.  E2 induced plasma vitellogenin to 1.4, 5.6, and 7 mg/ml (0.5, 2.5, and 7.5 
mg/kg in diet, respectively), while concomitantly reducing total liver CYP, in a dose 
dependent manner, to 37% that of  control fish.  When fed tamoxifen alone (1, 10, and 100 
mg/kg), vitellogenin in plasma ranged from 190 - 650 flg/ml, while total liver CYP did not 
change.  Tamoxifen cotreatment with 2.5 mg/kg E2 blocked the downregulation ofCYP 
and reduced plasma vitellogenin to levels comparable to fish fed tamoxifen alone. 
Tamoxifen was unable to completely block Vg induction or CYP downregulation at the 
highest (7.5 mg/kg) E2 dose.  Sex differences were observed, as females were more 
susceptible to CYP modulation, and more sensitive to V g induction, than males.  Lauric 
acid hydroxylation (LA-OR), used to estimate CYP activity, was not affected by low 
doses ofE2 or tamoxifen, but 100 mg/kg tamoxifen and mixtures of2.5 mg/kg E2 plus 100 
or 250 mg/kg tamoxifen significantly increased activity.  Our results show that 94 
tamoxifen antagonized E2 mediated effects in trout.  The data suggest that tamoxifen 
interacted with the trout estrogen receptor as a partial agonist and that the downregulation 
of  liver CYP by E2 is mediated, in part, by estrogen receptors. 95 
Introduction 
Endocrine systems of  animals are sensitive to modulation by xenobiotics.  Wildlife 
populations, particularly aquatic species, have been affected by endocrine active chemicals 
(EACs) (1,2) and numerous chemicals have been identified that interact with hormone 
receptors.  A variety of  studies have suggested that human health may be impaired by 
EACs, including increased rates of  cancer and reproductive abnormalities; however, the 
data are inconclusive (3).  Much of  the recent work on EACs has focused on chemical 
interactions with estrogen receptors (ER) (4,5), but research is needed to understand the 
complexity of  responses in vivo (6).  The effects ofEACs on hormone metabolizing 
enzymes, including CYP, have not been studied extensively. 
Cytochrome P450 proteins are involved in Phase I metabolism ofxenobiotics, as 
well as synthesis and metabolism of  endogenous steroids (7).  Steroid hormone production 
and function at target tissues are regulated by feedback loops involving the hypothalamo-
pituitary axis, which may be altered by xenobiotic-induced changes in CYP-mediated 
steroid metabolism (8,9).  The involvement ofCYP in sexual development has been 
documented, particularly the inhibition ofaromatase (CYP19) (10), which is a potential 
site of  toxicant impact.  Determining the regulation and consequences ofCYP modulation 
in fish will help to assess the risk ofEAC exposure in natural aquatic populations.  Insight 
into the evolution, structure and function of  human CYP has been gained from the 
characterization of  various rainbow trout CYP (11). 
Tamoxifen (TAM) is a pharmacological agent used in the treatment of  estrogen-
dependent breast cancer and it is being proposed as a chemopreventive agent.  Originally 96 
designed to be antiestrogenic, the estrogenic activity oftamoxifen is regulated by 
transcription factors present in target tissues, not solely by interaction with estrogen 
receptors (12).  Tamoxifen blocks estrogen-mediated growth in breast tissue but enhances 
estrogen receptor-mediated responses in the uterus and endometrium.  This example 
illustrates the difficulty of  predicting the in vivo activity of  estrogens or xenoestrogens 
based only on their affinity for estrogen receptors.  There are no reports of  the 
estrogenicity oftamoxifen in trout or its effect on fish CYP.  Tamoxifen has the potential 
for use as an antiestrogen in trout and as a model chemical for the study of  tissue specific, 
or weakly agonistic, xenoestrogens. 
Reports oflower CYP levels in adult female fish, compared to males, suggested 
that natural estrogens were involved in suppressing CYP (13).  Previous studies with the 
natural estrogen 17j3-estradiol (E2)  have demonstrated that trout CYP are susceptible to 
downregulation by estrogens (14,15), but the mechanisms of  modulation are unknown.  A 
variety ofxenobiotics inhIbit CYP in trout, often interacting directly with the enzymes 
(16).  Here, we describe studies designed to determine if  CYP modulation by E2 in trout is 
antagonized by tamoxifen, which would suggest involvement of  the estrogen receptor in 
CYP downregulation.  The estrogenicity oftamoxifen and effects on liver CYP were also 
investigated.  Vitellogenin (V  g), a phospholipoglycoprotein produced in response to 
estrogen receptor binding (17), was used as a biomarker of  liver estrogen receptor 
activation (18,19). 97 
Methods 
Chemicals 
Tamoxifen (TAM; [z  ]-I-[p-dimethylaminoethoxyphenyl]-1 ,2-diphenyl-l-butene; 
minimum 99% pure) and  17~-estradiol (E2)  (minimum 98% pure) were obtained from 
Sigma Chemical Co. (St. Louis).  [14C]-Lauric acid, biotinylated donkey anti-rabbit IgG 
and streptavidin linked horseradish peroxidase were purchased from Amersham (Arlington 
Heights,IL).  All other chemicals were of  reagent grade or better. 
Trout exposure 
Immature rainbow trout, 16 month old males and females, were reared at the core 
facility of  the MarinelFreshwater Biomedical Sciences Center at Oregon State University. 
Fish from each treatment were maintained, with IACUC approval, in 3' diameter tanks 
supplied with continuously running, 12°C well water.  Trout were fed a maintenance 
ration of2.8% (w/w) Oregon Test Diet (OID) (20) containing E2,  tamoxifen, or mixtures 
ofE2 and TAM.  In the first experiment, eighteen fish per treatment were fed the following 
doses for four weeks:  OID; 0.5,2.5, or 7.5 mglkg E2;  1,  10, or 100 mglkg tamoxifen; or, 
2.5 mglkg E2 mixed with 1, 10, 100, 250, or 500 mglkg tamoxifen.  After 1, 2, and 4 
weeks, six fish from each treatment were deeply anesthetized in tricainemethanesulfonate 
(MS222), blood was collected in heparinized syringes, livers were removed and snap 
frozen in liquid nitrogen, and fish were killed by severing the spinal cord.  Blood was kept 
on ice (maximum 6 h) until centrifugation at 3000 g for 10 min to isolate plasma.  Livers 
and plasma were frozen at -80°C until use.  In an additional experiment, twelve fish per treatment were fed OID alone or containing 7.5 mg/kg E2, 250 mg/kg tamoxifen or 7.5 
mg/kg E2 + 250 mglkg tamoxifen, for one week.  Livers and blood were collected as 
described above. 
Liver microsomes and LSI 
98 
The liver somatic index (LSI) was determined for each fish and represents the 
percentage of  total body weight contributed by the liver.  Microsomes were prepared from 
individual livers as previously descn"bed (21).  Microsomes were washed and stored at 
-80°C after resuspension in 0.1  M potassium phosphate buffer, pH 7.4, containing 1 mM 
EDTA and 20% glycerol.  Total cytochrome P450 content was estimated from the CO-
difference spectrum (22).  Protein content was determined using the method of  Lowry et 
al. (23). 
Enzyme activity 
The activity of  lauric acid hydroxylase (LA-OH) in liver micro  somes was estimated 
in vitro using the method described by Giera and van Lier (24).  LA-OH activity has been 
characterized as a marker for trout CYP 2KI (25,26).  Incubation mixtures contained 0.2-
0.4 mg protein, 100 JlM C
4C]-lauric acid, 1 mM NADPH, 1 mM MgCh and 5 mM KCl, in 
50 mM Tris-HCl, pH 7.4.  Reactions were run for 60 min at 30°C, throughout which time 
hydroxylation rates were linear. Vitellogenin ELISA 
A competitive enzyme-linked immunosorbent assay (ELISA) for V g, modified 
from Donohoe and Curtis (19) and described elsewhere (27), was used to determine 
plasma vitellogenin levels.  Plasma aliquots were thawed a single time and dilutions that 
fell within the linear portion of  the standard curve were used to estimate Vg.  Rainbow 
trout vitellogenin was purified for use as standards (28) and detected by cross-reactivity 
with IgG raised against chum salmon Vg (provided by A. Hara, Hokkaido University). 
Western blots confirmed that anti-salmon IgG recognized rainbow trout Vg.  There was 
no evidence of  non-specific antibody binding to either microtiter plates or proteins. 
Data analysis 
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Experiments were designed with the intention of  gathering data from individual 
fish and comparing the means from all fish in each treatment.  However, vitellogenin levels 
suggested possible sex differences, which was unexpected in immature fish.  Because of 
unequal sex ratios in some treatment groups, only livers from two males and two females 
were analyzed for CYP endpoints in low dose treatments  Final analyses include 
vitellogenin data from all fish and CYP data from four fish per treatment, unless noted. 
ANOVA and Student's t-test were used to compare results in different treatment groups 
(Microsoft Excel v7.0 and StatView v4.5, Abacus Concepts, Berkeley).  Covariance of 
fish weights were compared to Vg levels by ANCOV  A.  Vitellogenin standards were set 
to a four parameter model using DeltaSoft 3 software (Biometallics Inc., Princeton, NJ) in 
conjunction with a Bio-Tek EL340 plate reader (Winooski, VT). 100 
Results 
Dietary exposure to both 17Jl-estradiol and tamoxifen resulted in vitellogenin 
induction in a dose-dependent manner (Fig. 4.1).  Plasma V g levels in E2 exposed fish 
were consistently higher than tamoxifen throughout four weeks of  feeding.  After one 
week offeeding, Vg reached 45% and 71 % of  TAM and E2 levels achieved, respectively, 
after four weeks of  exposure (data not shown).  Maximum plasma Vg induced by TAM 
was 654 J.lg/ml, which was 11  fold lower than the maximum of  7 mg/ml induced by E2• 
Tamoxifen was much less potent than E2 as well, with maximal induction at 100 mg/kg 
significantly less than the lowest E2 dose of  0.5 mg/kg (p<0.05).  Males fed 1 mg/kg TAM 
seemed to have lower plasma V  g than females, but the lack of  statistically significant 
differences (p>0.05) may have been due to small sample size.  Fish fed OID alone 
averaged 148 ng V  g/ml plasma, which was slightly above the detection limit of  the assay 
(62.5 ng/ml).  Mean fish weights varied between some treatment groups, but no 
correlation between weight and V  g levels was observed (linear regression and ANCOV  A 
analyses).  Induction ofvitellogenin suggested that tamoxifen acted as a partial estrogen 
receptor agonist in rainbow trout liver. 
When fed varying doses oftamoxifen in combination with 2.5 mg/kg E2,  Vg 
decreased compared to fish fed E2 alone (Fig. 4.2).  Tamoxifen was also able to block E2-
dependent increased LSI and decreased total liver CYP (Table 4.1).  E2 feeding caused a 
dose-dependent decrease in total liver CYP.  Tamoxifen alone had few effects on liver 
parameters.  The LSI of  10 mg/kg TAM treated fish was significantly increased. but higher 
and lower doses oftamoxifen had no effect on LSI.  Total CYP levels were unchanged in ~  ...... 
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Figure 4.1- Plasma vitellogenin induction by 17J3-Estradiol (E2)  and tamoxifen (TAM). 
Error bars represent SEM ofthe mean (n=6).  Background Vg in controls was 148 ng/ml. 
a,b,c,d different letters indicate significantly different Vg (p<0.05). 102 
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Figure 4.2- Plasma vitellogenin in trout fed mixtures of 1713-estradiol (E2)  and tamoxifen 
(TAM).  Error bars represent SEM of  the mean (n=6).  * significantly lower than E2 
(p<O.OI). Table 4.1 - Modulation ofliver Cyp b~  17~-estradiol and tamoxifen
8 
LSIh  Total CYP  LA-OH 
Treatment  (nmollm~ Eroq  ~nmollm~ Erot./minl 
OTD  0.70 ± .07  0.189 ± 0.03  0.095 ± 0.03 
0.5 mg/kg E2  1.24±0.10*  0.168 ± 0.01  0.135 ± 0.04 
2.5 mg/kg E2  0.86 ± 0.10  0.129 ± 0.01  0.087 ± 0.01 
7.5 mg/kg E2  1.67 ± 0.16*  0.070 ± 0.01 *  0.084 ± 0.03 
1 mg/kg TAM  0.92 ± 0.02  0.187 ± 0.02  0.125 ± 0.01 
10mg/kg TAM  1.0 ± 0.10*  0.199 ± 0.01  0.121 ± 0.03 
100 mg/kg TAM  0.74 ± 0.05  0.182 ± 0.04  0.181 ± 0.04
c 
2.5 mg/kg E2 + 1 mg/kg TAM  1.18±0.12*  0.124 ± 0.02  0.140 ± 0.02 
2.5 mg/kg E2 + 10 mg/kg TAM  1.34 ± 0.14*  0.142 ± 0.02  0.116 ± 0.05 
2.5 mg/kg E2 + 100 mg/kg TAM  0.94 ± 0.04  0.181  ± 0.03  0.253 ± 0.04* 
2.5 mg/kg E2 + 250 mg/kg TAM  0.92 ± 0.05  0.180 ± 0.03  0.165 ± 0.02* 
2.5 mg/kg E2 + 500 mg/kg TAM  0.69 ± 0.05  0.201 ± 0.05  0.132 ± 0.02 
aFour week dietary exposure, values are means ± SEM (LSI n=8, CYP and LA-OH n=3 or 4) 
bLSI=liver somatic index; percent of  body weight contributed by liver 
CSignificantly greater than OTD controls when expressed as turnover (nmollminlnmol CYP; p<0.05) 
*Signifcantly different than OTD controls (p<0.05) 104 
all tamoxifen treatments.  Interestingly, lauric acid hydroxylase activity increased in fish 
fed 100 mg/kg tamoxifen for four weeks (Table 4.1).  One fish in that treatment had low 
LA-OH activity, which was due to low total CYP content.  The mean increase in LA-OH 
activity was not significant (p =  .08) unless LA-OH activity was expressed as turnover 
rather than specific activity (p < .05).  All other trends were identical whether LA-OH 
activity was reported as turnover or specific activity.  Combinations ofE2 and tamoxifen 
induced LA-OH activity up to 2.7 fold higher than corresponding tamoxifen, E2, or 
control fish (Table 4.1). 
Results from fish fed high doses ofE2 and tamoxifen for one week were slightly 
different than those from lower dose treatments.  Exposure to 7.5 mg/kg E2 induced 
plasma vitellogenin to levels 63 fold higher than 250 mg/kg tamoxifen.  Unlike lower E2 
dose combinations, tamoxifen could not fully counter the induction ofVg by 7.5 mg/kg E2 
(Fig. 4.3).  Treatment with a mixture of250 mg/kg TAM and 7.5 mg/kg E2 resulted in 
plasma V  g levels significantly lower than E2 alone, but also significantly higher than 
tamoxifen alone (Fig. 4.3).  Males fed 250 mg/kg TAM for one week had plasma Vg 
levels of20 ± 3 J.lg/ml, which were significantly less than female levels of 106 ± 20 J.lg/ml 
(p=.001).  Males and females produced equivalent amounts ofVg when fed 7.5 mg/kg E2 
for one week. 
Trends in liver CYP from high dose treatments were similar to Vg results.  E2 
treatment caused a significant reduction in total CYP which, contrary to lower dose 
mixtures, was not antagonized by tamoxifen (Table 4.2).  Unlike the four week treatments 
with lower tamoxifen doses, 250 mg/kg TAM in diet resulted in decreased total liver CYP 
(Table 4.2).  When male fish were compared, there were no statistically significant 105 
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Figure 4.3- Plasma vitellogenin in trout fed high doses of 17f3-estradiol (E2)' tamoxifen 
(TAM), or E2 + TAM.  Error bars represent SEM of  the mean (n=12).  asignificantly 
lower than E2 or mixture (p<O.05).  bsignificantly lower than E2 (p<O.Ol). Table 4.2 - Modulation of  liver CYP b  hi  h doses of 17  -estradiol and tamoxifena 
Treatment  LSI  Total CYP (nmollmg prot)  LA-OH (nmollminlmg prot) 
Males  Females 
OTD  1.12±0.05  0.251  ± 0.03  0.319 ± 0.02  0.293 ± 0.02 
7.5 mg/kg E2  1.22 ± 0.04  0.184 ± 0.03  0.211  ± 0.01 *  0.143±0.01* 
250 mg/kg TAM  1.09 ± 0.05  0.198 ± 0.03  0.130 ± 0.01 *c  0.074 ± 0.01 * 
7.5 mg/kg E2 + 250 mg/kg TAM  1.15 ± 0.03  0.213 ± 0.02  0.205 ± 0.02*  0.120 ± 0.02* 
aOne week dietary exposure (n=8), values are means ± SEM. Sex differences were only evident for total CYP. 
bLSI=liver somatic index 
cFemale CYP lower than males (p=O.03) 
*significantly different than OTD controls (p<O.OI) 
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reductions in CYP content, although levels in E2 fed male fish seemed lower than controls 
(p=.07).  Females were more susceptible to CYP downregulation, with significant 
reduction in all high dose treatments (Table 4.2).  Effects in males and females appeared to 
be different in lower dose treatments, as well, but only two males and two females from 
each treatment were assayed for CYP so statistical comparisons of  sexes were impossible. 
Lauric acid hydroxylation decreased at all high dose treatments (Table 4.2), but activity in 
males and females was similar. 
LSI did not change after only one week of  feeding, contrary to a greater than two 
fold increase in fish fed 7.5 mglkg E2 for four weeks.  Liver hypertrophy is likely to be due 
to changes associated with V  g production (19), but increased liver size was not required 
to increase plasma V  g levels in one week, high dose exposures.  Total CYP content also 
decreased in the absence of  changes in LSI (Table 4.2). 108 
Discussion 
Tamoxifen appears to be a partial estrogen receptor agonist in rainbow trout liver. 
We did not determine directly whether tamoxifen interacts with trout estrogen receptors, 
but Flouriot et al. (29) showed that 4-0H-tamoxifen prevented ER mediated gene 
transcription in rainbow trout hepatocyte cultures.  Vitellogenin production is thought to 
be mediated solely by estrogen receptor binding (17), suggesting that tamoxifen binds to 
hepatic ER to induce the Vg production seen in vivo.  Nimrod and Benson (30) reported 
tamoxifen binding to catfish ER, but Vg was not induced in vivo (31).  Our findings that 
tamoxifen had lower potency and efficacy than 17p-estradio~ with respect to Vg 
induction, are consistent with mammalian models that suggest tamoxifen is a partial 
estrogen receptor agonist (12). 
Decreases in liver CVP by E2, which were consistent with earlier studies (14,15), 
appear to be regulated by ER binding.  At a dose of2.5 mg/kg E2, tamoxifen was able to 
suppress E2 induction of  vitellogenin, resulting in V g levels comparable to fish fed 
tamoxifen alone.  Cotreatment with 100 fold excess tamoxifen also prevented the increase 
in LSI and decrease in total CYP expression seen with E2 alone.  At a higher E2 dose of 
7.5 mg/kg, tamoxifen doses 33 times in excess ofE2 (by weight) reduced the estrogenic 
responses in liver, without completely restoring parameters to levels when fed tamoxifen 
alone.  The affinity oftamoxifen tor trout liver ER may, therefore, be close to 100-fold 
less than E2, which would mean a greater excess oftamoxifen was needed to fully 
counteract the 7.5 mg/kg dose ofE2.  A lower threshold for Vg induction than CVP 
modulation was observed, as evidenced by plasma V g present in low dose tamoxifen and 109 
o.S mg/kg E2 treated fish in the absence of  changes in liver CYP content or activity. 
Estrogen receptor activation itself is therefore not sufficient to downregulate CYP, rather 
a threshold must be reached or an additional mechanism may be involved. 
In  the low dose study, E2 alone had no effect on lauric acid hydroxylation but in 
combination with 100 and 2S0 mg/kg tamoxifen, activity was significantly increased 
compared to controls.  When expressed as turnover (nmol LA-OHlminlnmol CYP), 100 
mg/kg tamoxifen alone also significantly increased LA-OR.  Estrogen receptor activation 
at those tamoxifen doses, predicted from V g induction, was significantly less compared to 
E2 alone.  It does not appear that induction of  LA-OR activity was due to high doses of 
tamoxifen alone, because SOO mg/kg TAM in combination with 2.S mg/kg E2 was not 
different from controls or E2 alone.  Additionally, 2S0 mg/kg TAM alone significantly 
decreased LA-OH activity in the one week feeding study.  High doses of  tamoxifen may 
inhibit CYP, specifically or non-specifically, by covalent binding of  metabolites or reactive 
intermediates, which has been observed in human and rat liver microsomes (32).  High 
dose tamoxifen treatment decreased total liver CYP in females, while V g induction to sub-
maximum levels suggested only partial ER activation.  The high dose of7.S mg/kg E2 
decreased total CYP in both studies, while LA-OH activity was decreased after one week 
but not four.  The different effects of  high doses oftamoxifen and E2, compared to lower 
dose mixtures and different time points, are puzzling.  IfLA-OH induction was mediated 
through the estrogen receptor in a classical manner, we would expect induction by E2 
alone.  We are currently investigating the specific CYP involved in the differential 
induction and inhibition ofLA-OH by different tamoxifen doses and mixtures, which may help to explain the mechanisms.  Nevertheless, the increased LA-OR activity seen with 
100 mg/kg tamoxifen and mixtures is the first evidence of  induction in trout. 
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Estrogen metabolism may playa role in receptor mediated responses.  Depending 
on the position of  hydroxyl groups, hydroxyestrone metabolites of  17~-estradiol can be 
highly (1OO-hydroxy) or weakly (2a-hydroxy) estrogenic (33).  The 2a-hydroxylation of 
17~-estradiol is catalyzed primarily by CYPIA2 in humans (34) and by CYP2Kl (LMC2) 
in rainbow trout (35).  In contrast, 16a-hydroxylation of  17~-estradiol is mediated by 
CYP2Cll in rat liver (36).  In trout, the catalyst for 1OO-hydroxylation of  17~-estradiol 
has not been identified.  Tamoxifen, or xenoestrogens, may alter CYP profiles resulting in 
changes in the ratio ofpotent:weak estrogen metabolites (37).  Different doses ofE2 and 
tamoxifen may alter CYP profiles such that more estrogenic metabolites are present after 
high dose treatments.  Some changes in CYP profiles seen here may be estrogen receptor 
independent, particularly high doses of  tamoxifen, but observations with sub-saturating E2 
doses suggest receptor involvement. 
Estrogen receptors are auto  induced in trout and saturation of  receptors (29) has 
been observed.  Studies in our laboratory have shown that 7.5 mg/kg E2 results in 
saturated plasma V  g levels, while 2.5 mg/kg was slightly below the saturation threshold 
(unpublished data).  Those results were consistent with the present data, in which fish fed 
2.5 mg/kg E2 seemed to have lower plasma V  g than 7.5 mg/kg treatments, but differences 
were not statistically significant.  The inability oftamoxifen to suppress the effects ofE2 at 
high doses may be due to different ER regulation at saturated levels.  Similar to trout, 
studies in catfish showed that tamoxifen alone did not induce Vg but 100 fold excess 
tamoxifen only partially blocked Vg induction at highly estrogenic ip doses (31).  Sex 111 
differences in V g induction in immature trout have recently been described for sub-
saturating E2 doses (27), which were also seen here at the 250 mg/kg TAM dose, but not 
at the high E2 dose (with or without tamoxifen cotreatment).  Sex differences were also 
observed with respect to CYP levels in high dose exposures ofE2 and tamoxifen, where 
total CYP content was significantly decreased only in females. The different responses of 
males and females may be due to differences in receptor number, however, receptor 
numbers were auto  induced to comparable levels in male and female salmon in vitro (38) 
and males and females produced equivalent amounts ofVg in this study at high estrogen 
doses.  Our results suggest that there may be fundamental differences in estrogen receptor 
regulation between sexes, which is supported by paradoxical effects oftamoxifen on 
sexual development of  alligators (39).  Alternative mechanisms could also explain our 
observations, such as stabilization of  receptor-ligand complexes or mRNAs at higher E2 
doses (40).  A single estrogen receptor cDNA, with multiple mRNAs, has been identified 
in trout (41), but multiple ERs have been identified in mammals, suggesting the possibility 
of  an additional trout receptor (42).  A thorough investigation of  estrogen receptor 
function in trout is needed to determine the mechanisms responsible for the differences in 
CYP content and V g induction seen with low and high dose estrogen treatment. 
Most xenoestrogens interact weakly with estrogen receptors in vitro (5,30) and we 
have observed that xenoestrogen potency and efficacy are generally lower than E2 in vivo 
(unpublished data).  In this study, receptor mediated downregulation ofCYP by E2 
occurred only at doses approaching or exceeding levels sufficient to saturate plasma V  g, 
but nominal environmental levels of  xenoestrogens are unlikely to be as potent.  There are 
likely to be species differences in response to xenoestrogens and partial estrogen agonists, 112 
as evidenced by different responses to tamoxifen and xenoestrogens in catfish (30,31) 
compared to trout and other species.  Ongoing investigations of  the modulation of  specific 
trout CYP isoforms and lauric acid hydroxylation sites by E2 and tamoxifen should help to 
clarifY estrogenic mechanisms. 113 
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Abstract 
Immature female rainbow trout, Oncorhynchus mykiss, ranging in age from six to 
eighteen months, consistently produced 3-4 fold higher amounts of  vitellogenin than 
similarly aged males.  The sex difference in vitellogenin induction is apparent after one 
week of  dietary exposure to 0.05 mg/kg 17p-estradiol.  Our results document the 
importance of  considering the sex of  juvenile fish when using vitellogenin production as a 
marker ofxenoestrogen exposure. 120 
Introduction 
Many xenobiotics interact with hormone systems of  animals, potentially leading to 
a phenomenon commonly called "endocrine disruption".  Much attention has focused on 
steroid hormone systems and corresponding receptor proteins, particularly estrogens [1,2]. 
Chemicals are routinely classified as hormone agonists or antagonists based on their 
interaction with receptor proteins in vitro, but, Nagel et aI.  [3] showed that in vitro 
receptor binding did not accurately predict estrogenic potency in mice.  Kavlock et aI.  [4] 
also reported the need for in vivo research to determine the mechanisms of  endocrine 
modulating chemicals. 
Vitellogenin (V  g), a phospholipoglycoprotein, is an egg yolk protein precursor 
produced in oviparous animals in response to estrogen receptor binding [5].  Mature 
females produce vitellogenin due to a rise in circulating estrogens, however, the presence 
ofvitellogenin in liver and plasma of  juvenile and male fish has been used as a biomarker 
of  estrogen and xenoestrogen exposure [6,7].  Elevated plasma vitellogenin levels have 
been found in wild male fish in the United Kingdom, which are thought to be due to 
contaminants and phannacological estrogens released in waste water effluent [8]. 
Understanding the role of  exogenously administered estrogens will help to determine the 
effects of  xenoestrogens in fish. 
Previous studies have reported vitellogenin protein and mRNA levels in 
xenoestrogen-exposed juvenile rainbow trout, as pooled samples of  males and females 
[7,9].  Immature saImonids lack secondary sex characteristics and they have low levels of 
circulating sex steroids. which have contributed to a common assumption that sexes are 121 
physiologically similar until sexual maturation.  Patmo and Schreck [10], however, have 
described sex differences in plasma sex steroids in immature coho salmon.  Studies in our 
laboratory suggested that immature male and female trout responded differently to 
xenoestrogens, as evidenced by vitellogenin production [11].  Here, we describe work 
with the natural estrogen I7J3-estradiol that demonstrates a sex difference in juvenile 
rainbow trout vitellogenin production. 122 
Materials and Methods 
Dietary J 7  ~estradiol  exposure 
Juvenile rainbow trout (Oncorhynchus mykiss), Shasta strain, were reared at the 
MarinelFreshwater Biomedical Sciences Center aquaculture facility at Oregon State 
University, as approved by the IACUC at O.S.U.  Thirty fish per treatment, ages three to 
eighteen months, were separated by age and maintained in 3' diameter tanks supplied 
continuously with 13°C well water.  Fish were fed a growth ration of5.6% diet per day 
(w/w) for seven days.  l7f3-Estradiol (E2)  (Sigma, St. Louis, MO) was dissolved in 95% 
EtOH and added to Oregon Test Diet (OID), a semi-purified trout diet [12].  Final dietary 
concentration ofE2 was either 0, 0.05, or 2.5 mg/kg, containing 0.025% EtOH (v/w). 
Doses were chosen to include diets known to induce sub-maximal and maximal V g 
production [11].  On day eight, fish were anesthetized in tricainemethanesulfonate 
(MS222) (50 mgIL) and blood was drawn into 3 ml vacutainers containing sodium 
heparin.  Livers were removed, sex was determined grossly by gonad morphology and fish 
were killed by severing the spinal chord.  A mixture of  EDT  A (1  mM) and aprotinin (50-
150 kallikrein unitslml) was added to whole blood to inhibit protealytic cleavage ofVg. 
Blood was immediately placed on ice and maintained at 4°C until plasma was isolated 
after centrifugation for 10 min at 3000 g (within 4 h after sampling).  Plasma was stored in 
aliquots at -80°C until use.  Total liver protein was determined by the method of  Lowry et 
al. [13]. 123 
Vitellogenin ELISA 
Vitellogenin was measured using a competitive enzyme-linked immunosorbent 
assay (ELISA), modified from Donohoe and Curtis [7].  Purified rainbow trout 
vitellogenin (D.R. Buhler, Oregon State University) was used to coat 96 well microtiter 
plates (25 ng V  glwell) and for standard solutions (0-1600 ng V  glml).  Vitellogenin was 
identified by polyclonal IgG antibodies (427 nglml) raised in rabbits against chum salmon 
Vg (A. Hara, Hokkaido University).  Vg standards were fit to a four parameter model 
using DeltaSoft 3 software (Biometallics Inc., Princeton, NJ) in conjunction with a Bio-
Tek EL340 plate reader (Winooski, VT).  There was no observed non-specific binding of 
antibody to plates or other plasma proteins, as verified by western blotting.  Samples from 
individual treatments were always measured within a single assay, however, we 
occasionally had to repeat analyses with additional plasma dilutions because of  variability 
between fish.  Intraassay variability was <10% and interassay variability <15%.  ANOV  A 
and Student's t-test analyses were performed with Microsoft Excel (v7.0) and StatView 
(Abacus Concepts, Berkeley, CA). 124 
Results 
Liver Somatic Index 
Individual fish and liver weights were recorded and compared within, and between, 
treatments.  Liver somatic index (LSI) was calculated for each fish and represents the 
percentage of  total body weight contributed by the liver.  LSI increased over basal levels 
in six month old fish fed 0.05 mg/kg E2,  from 1.2 ± 0.2 to 1.9 ± 0.3 in females (p<O.OOl) 
and from 1.2 ± 0.1  to 1.7 ± 0.3 in males (p<O.OOI).  High dose E2 exposure of2.5 mg/kg 
resulted in higher LSI in twelve month old fish (females 1.5 ± 0.2, males 1.5 ± 0.4) 
compared to age-matched fish fed 0.05 mg/kg (females 1.3 ± 0.1, males 1.2 ± 0.2) 
(p<0.01).  Neither individual fish weight nor LSI differed between sexes in any treatment 
groups. 
Plasma and liver vitel/ogenin 
One week dietary exposure to 0.05 or 2.5 mg/kg E2 resulted in the production of 
vitellogenin in all fish, ranging in age from 3 to 18 months.  V  g was present in plasma of 
unexposed 12 and 18 month old females (0.556-58.1  J.1g Vg/ml range) but not in males 
(detection limit was 62.5 ng/ml at 1: 1  0 plasma dilution).  In fish aged six to eighteen 
months, females produced more Vg than males after feeding 0.05 mg/kg E2•  Vg averaged 
70.8 ± 12.3 ng/mg protein in livers of  three month old fish, however, comparisons 
between sexes were not made because gonads were too small to identifY the sex grossly. 
In six month old fish, Vg was 3.7x higher in female livers than in males after adjusting for 
total liver protein content (Fig. 5.1).  V  g was 4.2x higher in plasma of  twelve month old 125 
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Figure 5.1- Liver vitellogenin in six month old trout fed 0.05 mg/kg 17J3-estradiol for 7 d. 
* indicates significantly lower vitellogenin production in males (p < 0.005). 126 
females and 3.3x higher in plasma of  eighteen month old females than similarly aged males 
(Fig. S.2).  When fed 2.S mg/kg E2,  twelve month old males and females produced similar 
amounts ofVg (4.84 ± 1.08 and 4.37 ± 1.03 mg Vg/rnl plasma, respectively; p>O.OS). 
There were no differences in the amount of  plasma Vg in sex-matched twelve and eighteen 
month old fish fed 0.05 mg/kg E2 (p>0.05).  The mean levels of  plasma V  g in twelve 
month old fish fed 2.5 mg/kg E2 were significantly higher than both twelve and eighteen 
month old fish fed O.OS mg/kg E2 (p<O.OOOI).  Trends in liver Vg were similar to plasma 
in twelve month old fish, with female V  g higher than males at low, but not high, E2 
exposure (data not shown). --- - a 
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Figure 5.2 - Plasma vitellogenin in twelve and eighteen month old trout fed 1713-estradiol 
for 7 d.  Solid bars represent females, open bars represent males.  * indicates significantly 
lower vitellogenin production in males (p < 0.001). 128 
Discussion 
Vitellogenin production by oviparous animals has proven to be a useful biomarker 
of  exposure to estrogenic chemicals [6,7].  Results from the current study document a sex 
difference in estrogen induced vitellogenin in immature trout, evident only if  fish are fed a 
dose ofE2 (0.05 mg/kg) that induces sub-maximum Vg production (26.3 - 110.5 J.1g 
V  g/ml plasma in males and females, respectively).  These observations are consistent with 
results from a previous study in our lab, in which tamoxifen blocked E2-mediated V  g 
production and liver cytochrome P450 downregulation only at sub-maximal E2 doses [11]. 
Flouriot et at.  [14] showed that trout estrogen receptor mRNA and Vg mRNA 
transcription are saturable by estrogens, and we have previously observed saturable 
plasma Vg for estrogenic chemicals with varying potency and efficacy (unpublished data). 
It is possible that previous studies failed to observe sexually dimorphic vitellogenin 
production in immature trout because of  highly estrogenic doses or long exposure times. 
Juvenile rainbow trout can only be sexed accurately by examination of  gonads and fish 
may not have been sexed in earlier studies.  Basal and induced vitellogenin levels varied 
greatly (up to 10-100 fold) between same-sex individuals, which was consistent with 
reported variability in fish of  comparable age, sex, and reproductive status [15].  Such 
high variability would make it difficult to see statistically significant sex differences in V  g 
induction with small sample sizes [7]. 
We are currently trying to determine the mechanism that promotes greater 
vitellogenin synthesis in immature females.  Sex differences may be due to different 
estrogen receptor regulation. as age, sex, and seasonal differences in estrogen receptor 129 
number, affinity, and regulation have been documented in trout [16,17].  Ultimately, when 
exposed to high E2 doses, immature males produced equivalent amounts ofVg as females 
(Fig. 5.2), which could be explained by auto  induction of  estrogen receptors to equivalent, 
saturated levels [16,14].  Alternatively, studies have shown that rainbow trout previously 
exposed to estrogens produce greater amounts ofVg and Vg mRNA [18,19], during 
subsequent estrogen exposure.  Imprinting by estrogens during development, or priming 
by low levels of  circulating estrogens, may predispose female trout to respond differently. 
than males to later estrogen exposure. 
Because immature fish have been used successfully to characterize estrogenic 
chemicals in vivo, these models are candidates for use in screening estrogenic chemicals, 
as mandated by the Congress of  United States in the Food Quality and Protection Act 
(1996) and the Safe Drinking Water Act (1996).  While the mechanisms of  sexually 
distinctive vitellogenin production are currently unknown, immature fish will continue to 
be useful models for in vivo xenoestrogen characterizations if  sex is considered in 
analyses. 130 
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Summary 
The data presented in this thesis confirm that rainbow trout are sensitive to 
xenoestrogens and useful for mechanistic studies of  endocrine modulation.  As expected, 
early life stages of  trout were more sensitive to xenobiotics than juveniles, evidenced by 
high lethality in embryos and fry.  The xenoestrogens investigated, however, were unable 
to produce consistent changes in sexual differentiation seen with natural estrogens. 
Nominal environmental DDE contamination is unlikely to induce changes in rainbow trout 
sexual development.  Other persistent chemicals may alter sexual development in trout (1), 
and species sensitivity may differ to xenoestrogen exposure during sexual differentiation 
(2).  The high doses of  o,p'-DDE and chlordecone injected into embryos were above levels 
that most natural populations would be exposed to and chemicals may interact with 
receptors at lower environmental levels (3).  It has been suggested that low doses of 
xenoestrogens may be more potent in vivo than high doses (4), but there is no evidence in 
fish to support that theory.  Embryos may be more sensitive to continuous aqueous 
exposure than to microinjections (2), because injection directly into yolk may result in 
chemicals associating with lipids and being sequestered away from developing sex organs. 
With respect to exposure to maternally transferred chemicals, acute toxicity of  the 
chemicals investigated in this thesis is likely to precede subtler endocrine effects in natural 
populations. 
Exposure to mixtures of  xenoestrogens was similar to what would be expected 
from additive, or competitive, binding to estrogen receptors.  Vitellogenin induction and 
P450 modulation were sensitive biomarkers for investigating chemical mixtures.  At lower 135 
relative estrogen doses, tamoxifen was able to block the effects of  17f3-estradiol on V  g 
and liver P450 in trout.  Mixtures of  natural estrogens and OH-PCBs also resulted in Vg 
induction suggested by additive receptor binding.  Estrogenic biomarkers were not, 
however, sensitive to unlimited chemical exposure.  Responses were saturated during 
short term in vivo exposures, which supports earlier findings that estrogen receptor 
binding is saturable and dependent on finite receptor numbers (5,6).  There was a high 
degree ofvariability in the responses of  individual fish to xenoestrogens, but maximal Vg 
induction was evident.  One result which could not be explained by classical ER binding 
was the induction of  lauric acid hydroxylase by mixtures oftamoxifen with sub-saturating 
levels of  estrogen. Tamoxifen alone did not appear to be solely responsible for LA-OH 
induction because the responses to E2 and tamoxifen mixtures were greater than with 
tamoxifen alone and treatment with the highest dose of  tamoxifen alone decreased enzyme 
activity. 
The importance of  estrogenic doses was documented by different responses in fish 
treated with saturating and sub-saturating amounts of  estrogens.  Environmental 
contaminants are unlikely to saturate estrogenic responses because of  weak affinity for 
estrogen receptors (3,7-9).  Responses seen with low doses of  natural estrogens are 
probably more applicable to xenoestrogen effects than high dose effects.  High doses of 
estrogens induced V  g to maximal levels, at which point sex differences in the vitellogenic 
response of  immature fish disappeared.  Tamoxifen was also unable to fully counteract the 
effects of  high doses of  estrogens, which may be due to toxic effects of  estrogens (10) or 
to non receptor-mediated mechanisms.  Another interesting finding was the ability of  4-
OH-2',4',6'-trichlorobiphenyl to induce Vg to saturated levels in vivo.  Although receptor 136 
affinity ofOH-PCB 30 is predicted to be about 40 fold lower than estradiol (11), the 
maximal V  g response was similar to natural estrogens, presumably because of  maximal 
receptor activation.  There may be different mechanisms involved in the activity and 
toxicity of  estrogenic chemicals, dependent on the extent and strength of  receptor binding 
and corresponding unbound chemicals. 
Sex differences in estrogen dependent responses were documented in immature 
trout, which were contrary to the common assumption that immature salmonids are 
physiologically similar until sexual maturity.  Vg induction and P450 downregulation 
occurred in both males and females, but the magnitude of  response to estrogens was 
different.  As noted above, the sexually dimorphic V  g response was observed only at 
doses of  xeno- and natural estrogens that induced V  g to less than saturated levels.  A 
sexually dimorphic downregulation of  hepatic P450s was significant with high dose 
treatment of  1713-estradiol and tamoxifen.  Similar trends were seen with lower dose 
estradiol treatments, but small sample sizes prevented statistical analyses.  Sexing 
immature trout is time consuming and invasive, but the results presented in this thesis 
document the importance of  sex specific responses to xenoestrogens. 137 
Future Directions 
Endocrine toxicology has received a tremendous amount of  attention recently from 
lawmakers and the public.  Clear, causal relationships of  adverse effects ofEACs on 
human health are lacking and documented toxicity in natural fish and wildlife populations 
has been limited to heavily contaminated areas.  The potential certainly exists for 
contaminants to affect endocrine systems, but scientists should be cautious about 
emphasizing isolated occurrences, in highly polluted environments.  It may be wise to 
concentrate resources and effort on the consequences of  low level, Ubiquitous 
contamination.  While high dose exposures facilitate mechanism-based studies, 
experiments with low, environmentally relevant doses should follow.  Work from vom 
Saal's lab showing that low doses ofxenoestrogens act differently than high doses in vivo 
(4) suggest that low level environmental contamination may be important.  The 
establishment of  thresholds for EAC effects in different species will provide important 
information for regulating chemicals. 
There is an important distinction between chemical exposure and adverse effects in 
an organism.  For example, the effects of  elevated vitellogenin in fish have not been 
addressed, though evidence in the field and the laboratory have shown xenoestrogens to 
induce V  g.  Some questions to consider about xenoestrogen induced vitellogenin include: 
Are male fish adversely affected by high levels of  circulating vitellogenin?; How long is Vg 
present in males and non-reproductive females?; Does xenobiotic induced vitellogenin 
induction in female fish alter normal reproductive function?; Is there a physiological role 
for V g in male fish?; Do normally silent genes, such as male V g genes. or male sex 138 
detennining genes in unisexual female lizards, serve a common evolutionary function? 
Mechanisms of  endocrine modulation must be determined before complex environmental 
effects can be understood.  Eventually, population and community structure should be 
addressed, in the context of  ecoregions and habitat, which ultimately reflect overall 
environmental health. 
Many interesting questions and avenues of  research could be pursued concerning 
the mechanisms of  sexually dimorphic responses of  immature trout to xenoestrogens.  It is 
not surprising that males responded differently than females to estrogens, because steroid 
expression is sexually dimorphic in mature fish (12).  Directly measuring estrogen receptor 
expression and activity would determine whether receptor-dependent biomarkers 
described in this thesis accurately predicted receptor responses.  It would be interesting to 
learn whether immature males simply have lower ER numbers than females, or whether 
gene regulation was controlled by other factors which are inherently different between 
sexes.  Research in our lab is currently investigating the persistence ofVg in male fish, as 
well as the implications of  prior estrogen exposure on the magnitude ofVg induction. 
Preliminary results have shown that sex differences are not due to physiological priming of 
females by natural estrogens, which suggests that estrogen regulation in immature males 
and females is fundamentally different (unpublished data).  Molecular tools could be used 
to determine the earliest time when sexually dimorphic responses occur, which could help 
clarify the mechanisms of  sexual differentiation in trout.  Investigating the different 
responses of  fish to high and low estrogen doses may provide interesting information 
about receptor-mediated gene regulation. 139 
There were many interesting observations in this thesis, and in related work, that 
were not pursued but that may have implications for toxicant effects in trout. 
Microinjected eggs hatched earlier than uninjected embryos, which may have been due to 
physical damage to the chorion.  Limited evidence with salmon suggested that toxicant 
doses may also decrease the time to hatch, but those data were confounded by injection 
stress to eggs.  It  could be that decreased time to hatch is a general stress response, 
unrelated to injection trauma, that may be important for fish exposed to low levels of 
toxicants.  Hatching of  underdeveloped embryos may increase mortality rates; higher 
mortality was noted in injected salmon that hatched earliest (personal observation). 
Decreased in vitro androgen production in male trout injected as embryos may have been 
due to a general stress response or to developmental changes caused by earlier hatching. 
Endogenous steroid production at maturity was not measured in affected males, but males 
from a mixed sex population reproduced successfully. 
Two other projects may provide useful tools for endocrine toxicology research. 
Attempts to identifY a pure antiestrogen in trout were unsuccessful; if  one is identified, it 
would assist investigations of  tumor promotion in trout by estrogens and xenoestrogens. 
By blocking estrogen receptor-mediated responses, the contribution of  estrogenic effects 
to toxicity and carcinogenesis could be separated from other mechanisms.  Identification 
of  trout aromatase inhibitors would be useful for blocking the conversion of  androgens to 
estrogens, which may be important in the hepatocarcinogenic activity of  the androgen 
dehydroepiandrosterone (DHEA).  Additionally, aromatase may be involved in trout sex 
determination or differentiation, which has been shown in reptiles (13, 14) and suggested in 
salmon (J 5).  Identification of  environmental contaminants that inhibit aromatase may provide interesting information about sex differentiation, endocrine modulation, and 
additional risks ofEACs. 
140 
Human society and the chemicals we produce affect the world around us.  The 
science of  toxicology (and science in general!) is undergoing an exciting period of 
discovery.  We have amazing molecular biology tools and a substantial knowledge of 
biology and chemistry at our disposal.  We are beginning to understand the mechanisms by 
which chemicals cause non-lethal physiological perturbations.  Endocrine active chemicals 
may prove to pose little risk to humans, but there are well documented cases of  adverse 
effects in wildlife.  Research proceeds slowly, however, and we must decide whether to 
err on the side of  caution or economic interests as we implement policy regarding new 
chemicals that we know little about. 141 
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